Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Articles

Page Path
HOME > Diabetes Metab J > Volume 37(1); 2013 > Article
Review
Obesity and Metabolic Syndrome AMPK and Exercise: Glucose Uptake and Insulin Sensitivity
Hayley M. O'Neill
Diabetes & Metabolism Journal 2013;37(1):1-21.
DOI: https://doi.org/10.4093/dmj.2013.37.1.1
Published online: February 15, 2013
  • 9,675 Views
  • 152 Download
  • 182 Crossref
  • 196 Scopus

Protein Chemistry and Metabolism Unit, St. Vincent's Institute of Medical Research, Fitzroy, Australia.

Corresponding author: Hayley M. O'Neill. Protein Chemistry and Metabolism Unit, St. Vincent's Institute of Medical Research, 9 Princes Street, Fitzroy, Victoria 3065, Australia. honeill@svi.edu.au

Copyright © 2013 Korean Diabetes Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • AMPK is an evolutionary conserved sensor of cellular energy status that is activated during exercise. Pharmacological activation of AMPK promotes glucose uptake, fatty acid oxidation, mitochondrial biogenesis, and insulin sensitivity; processes that are reduced in obesity and contribute to the development of insulin resistance. AMPK deficient mouse models have been used to provide direct genetic evidence either supporting or refuting a role for AMPK in regulating these processes. Exercise promotes glucose uptake by an insulin dependent mechanism involving AMPK. Exercise is important for improving insulin sensitivity; however, it is not known if AMPK is required for these improvements. Understanding how these metabolic processes are regulated is important for the development of new strategies that target obesity-induced insulin resistance. This review will discuss the involvement of AMPK in regulating skeletal muscle metabolism (glucose uptake, glycogen synthesis, and insulin sensitivity).
AMPK
AMPK is an evolutionary conserved αβγ heterotrimer consisting of an α catalytic subunit and βγ regulatory subunits. In mammals, all subunits are required for a stable complex and full activation of the enzyme [1]. AMPK is activated by low energy status (increased AMP/ADP: ATP) such as during exercise, and regulates metabolic process and energy homeostasis by switching off ATP consuming pathways (fatty acid and cholesterol synthesis) and switching on ATP generating processes (glucose uptake and fatty acid oxidation).
AMPK αβγ heterotrimer expression in skeletal muscle
Skeletal muscle predominately expresses α2β2 complexes with low levels of α1 and β1. AMPK γ1 and γ2 are expressed in multiple tissues [2] whereas γ3 appears to be restricted to skeletal muscle [3-6], where it's association with α and β isoforms differ depending on the fiber composition of the muscle. In mice, γ3 and γ2 AMPK is predominately expressed in fast-twitch glycolytic extensor digitorum longus (EDL) muscle compared to slow-twitch oxidative soleus muscle [4,5] whereas in gastrocnemius muscle, γ1, γ2, and γ3 are evenly expressed [5]. In mice, both AMPK β1 and β2 associate with α2 in EDL whereas β1 AMPK is primarily associated with α2 AMPK complexes in soleus [7]. In humans, α1 and β1 are primarily expressed in slow-twitch oxidative [8] whereas γ3 is predominantly expressed in fast-twitch glycolytic muscle [9]. In human skeletal muscle, the majority of AMPK α2/β2 complexes associate with γ1, whilst the remaining α1/β2 and α2/β2 associate with γ3 [10]. See Table 1 for AMPK isoform heterotrimer distribution in EDL and soleus.
Regulation of AMPK activity: upstream kinases and allosteric regulation
AMPK is inactive unless phosphorylated on the α-subunit activation loop at T172. Both AMP and ADP binding to the γ subunit enhances T172 phosphorylation and suppresses dephosphorylation [11-13]. Phosphorylation is the most potent activator of AMPK increasing activity >100 fold [14]. Upstream kinases, LKB1 and Ca2+/calmodulin-dependent protein kinase kinase (CaMKK) phosphorylate AMPK T172 in mammalian cells. LKB1 is a heterotrimer complex with regulatory proteins STRAD and MO25 [15,16]. In skeletal muscle, studies in two independent models lacking LKB1 have shown that LKB1 is the major AMPK kinase in skeletal muscle [17,18]. Skeletal muscle-specific deletion of LKB1 (LKB1-MKO) from mice results in greatly reduced α2 AMPK T172 phosphorylation following activation by AICAR (a cell-permeable adenosine analog that can be phosphorylated to form 5-aminoimidazoel4-carboxamide-1-d-riborfuronosil-5'monophosphate) or muscle contractions/exercise [17-19]; however, AMPK α1 activity does not appear to be substantially reduced in these models suggesting an alternative upstream kinase may regulate AMPK α1 activity. CaMKK activates AMPK in response to elevated intracellular Ca2+ [20-22]; however, there is a lack of genetic evidence supporting the importance of this kinase in regulating skeletal muscle AMPK T172 phosphorylation.
Insulin resistance
Skeletal muscle constitutes around 45% of lean body mass and is a highly metabolic tissue that is a major contributor to whole-body expenditure. Skeletal muscle is responsible for around 80% of insulin-stimulated glucose disposal [23-25]; therefore, responsiveness to insulin in this tissue is important for regulating whole-body insulin sensitivity. Over the past decade, reduced physical activity levels, due to increasing technologies that promote a sedentary lifestyle and the overconsumption of food, has led to an epidemic of obesity and type 2 diabetes. Obesity and type 2 diabetes are casually linked through their association with skeletal muscle insulin resistance. Insulin resistance is characterized by the reduced responsiveness of target tissues (e.g., skeletal muscle, liver and adipose tissue) to insulin. This results in compensatory hyperinsuliemia, but hyperglycaemia and hyperlipidemia due to the reduced ability of insulin to suppress liver gluconeogenesis and promote glucose uptake in skeletal muscle. Insulin also promotes glucose uptake into adipose tissues and suppresses lipolysis. Therefore, understanding the underlying mechanisms that contribute to the development of insulin resistance as well the pathways involved in improving insulin sensitivity are critical for the development of new strategies (both pharmacological and non-pharmacological such as exercise) that target obesity-induced insulin resistance. Activation of AMPK by pharmacological means have supported a role for AMPK in regulating glucose uptake, fatty acid oxidation, mitochondrial oxidative capacity and insulin sensitivity; therefore, AMPK may be potential target for the treatment of obesity induced insulin resistance given these processes are reduced in skeletal muscle from obese and type 2 diabetic humans and rodents.
Whole-body α1, α2 [26], β1 [27], β2 [28,29], and γ3 [4] KO and muscle-specific β1β2 KO (β1β2 M-KO) [30] mice as well as transgenic mice overexpressing a kinase dead form of α2 AMPK in skeletal muscle (KD or α2iTg) [31,32] have been generated to help define the role of AMPK in regulating skeletal muscle metabolism. These studies have investigated the role of AMPK in regulating carbohydrate (glucose uptake and glycogen synthesis) and lipid (fatty acid uptake and oxidation) metabolism, and mitochondrial biogenesis and insulin sensitivity at rest and during or following exercise and muscle contractions.
AMPK α
AMPK α2 KO and α2KD mice have reduced AMPK T172 phosphorylation and α2 activity in skeletal muscle, but enhanced or modestly reduced α1 activity, respectively [31,33,34]. In contrast, AMPK α1 KO mice have normal AMPK T172 phosphorylation in skeletal muscle despite reduced α1 activity, showing that α2 AMPK is the predominant isoform contributing to AMPK activity in skeletal muscle [35]. The role of AMPK in insulin sensitivity has been extensively studied in AMPK deficient models fed either a chow or high-fat diet, the latter being considered the most physiological model to replicate human obesity and insulin resistance in rodent studies. AMPK α1 KO and α2KD mice have normal insulin sensitivity on a chow and high-fat diet [33,36]. However, an alternative muscle-specific mouse model on a model FVB background, rather than a C57Bl6 background, overexpressing a muscle-specific KD AMPKα2 B157A mutation (α2iTg), are glucose intolerant and develop exacerbated skeletal muscle insulin resistance when fed a high-fat diet for 30 weeks, which occurs independently of an increase in muscle lipids [37]. In this study, high-fat fed α2iTg mice had reduced IRS1 and Akt protein expression in skeletal muscle compared to WT counterparts, which may have contributed to the reduced skeletal muscle glucose uptake in response to insulin [37]. The FVB strain is known to be resistant to obesity-induced insulin resistance and given that the greater glucose intolerance in α2iTg mice was not evident until after 26 weeks on the high-fat diet, it is unlikely that AMPK is directly involved. Whole-body AMPK α2 KO mice have reduced insulin secretion and whole-body insulin-stimulated glucose utilization due to elevated catecholamine levels and a hyperactive sympathetic nervous system [33]. Basal and insulin-stimulated glucose uptake in isolated muscles is normal in AMPK α2 KO mice, further supporting that insulin resistance was caused by an external defect independent of skeletal muscle AMPK.
AMPK β
Whole-body deletion of both β1 and β2 is embryonic lethal [38]. AMPK β1 KO mice have reduced AMPK activity in liver but not skeletal muscle, are hyperphagic and as a result have lower body weight, adiposity and hepatic lipid accumulation, and are protected from high-fat diet induced insulin resistance [27]. In contrast, AMPK β2 KO mice have reduced AMPK activity in skeletal muscle but not liver or adipose, and have a compensatory increase in AMPK β1 protein expression and maintained α1 expression in skeletal muscle [28]. AMPK β2 KO mice are characterized by reduced exercise capacity and increased susceptibility to develop insulin resistance on a high-fat diet possibly due to greater ceramide accumulation in skeletal muscle [28]. Interestingly, lipid accumulation occurred in AMPK β2 KO mice despite intact fatty acid oxidation rates and increased glycogen utilization in skeletal muscle [28]. An alternative AMPK β2 KO mouse model has recently been generated and these mice have a similar phenotype the β2 KO model reported by Steinberg et al. [28], but in addition, show that AMPK plays an important role in the adaptive response to fasting whereby AMPK β2 KO mice have reduced phosphorylation of S6K and the AMPK substrate ULK1, which is involved in autophagy [29,39].
We have recently generated muscle-specific AMPK β1β2 double KO mice (β1β2M-KO) to alleviate concerns related to residual AMPK activity due to remaining subunit homologs being present or upregulated in previous AMPK deficient models (α2 KO, α2KD, β2 KO, γ3 KO). As anticipated, AMPK β1β2M-KO mice have undetectable levels of AMPK activity at rest or during exercise [30]. Their phenotype is more dramatic compared to whole-body AMPK β2 KO mice [28] and is characterized by dramatically reduced voluntary wheel activity (75%), maximal exercise capacity (95%), mitochondrial content (30%) and exercise-mediated glucose uptake in skeletal muscle (55% to 70%) [30]. Interestingly, young (9 to 12 weeks) AMPK β1β2M-KO mice have similar whole-body weight and adiposity, and consistent with this, whole-body and skeletal muscle specific insulin sensitivity is similar when compared to wild-type littermates [30]. These studies highlight an important role for AMPK in regulating exercise capacity, mitochondrial content and glucose uptake during exercise, but not insulin sensitivity.
AMPK γ
The γ1 subunit is ubiquitously expressed similar to γ2; however, γ2 expression is predominant in heart [2,3]. In contrast, γ3 appears to be expressed specifically in skeletal muscle [3-6]. Studies from both whole-body γ3 KO and transgenic γ3 overexpressing or gain-of-function mice have revealed an important role for the γ3 subunit in regulating glucose uptake, glycogen synthesis, fatty acid oxidation and mitochondrial biogenesis in skeletal muscle [40]. Whole-body γ3 KO mice have reduced AMPK activity at rest, during exercise and in response to fasting, but normal insulin sensitivity under basal conditions and glucose uptake during exercise [4,41]. Interestingly, gain-of-function mutations in the γ subunits result in glycogen storage disease in humans [42-44] and pigs [45]. AMPK γ3 R225Q mutation is the most studied mutation and this mutation is homologous to R225Q in Hampshire pigs, as well as AMPK γ2 R200Q in humans, which is associated with Wolff-Parkinson-White syndrome [46,47]. Interestingly, transgenic mice harboring the R225Q mutation in AMPK γ3 subunit have higher AMPK activity and glycogen levels and are protected from diet-induced insulin resistance [4], which is a likely effect of increased fatty acid oxidation and subsequent reduction in skeletal muscle lipids. Mice with an AMPK γ3 R225Q mutation are also fatigue resistant during exercise whereas AMPK γ3 null mice are prone to fatigue during exercise and have impaired glycogen re-synthesis following exercise (see section AMPK and glycogen synthesis) [4,48]. Whilst γ3 appears to be predominantly expressed in glycolytic muscles, training reduces γ3 expression in humans [10,49], which may be an adaptive response to enhanced oxidative capacity (preference for lipid oxidation). These studies suggest that targeting AMPK may enhance exercise performance and be protective against insulin resistance disease development in obesity.
An important feature of skeletal muscle is its ability increase ATP turnover (>100 fold) during exercise in order to provide energy for contracting muscles [50]. Under such conditions, AMP and ADP levels are rapidly increased in an intensity-dependent manner and ATP levels decline slightly. AMPK is a sensor of cellular energy status that is activated by AMP and ADP. Consistent with this, AMPK is activated during exercise in both rodents and humans [51-60], in an intensity-dependent manner [57,59-61]. Both AMPK α1 and α2 are activated during exercise; however, α1 activity appears to be increased during high intensity muscle contractions, which are equivalent to >100% maximal oxygen consumption (VO2 Max; measure of maximal exercise capacity) [59,62,63]. In contrast, α2 activity is increased at low intensity exercise starting at 40% VO2 Max and increases progressively with exercise intensity.
Exercise can also regulate glucose uptake by an insulin-independent mechanism involving AMPK [30]. Importantly, GLUT4 translocation during exercise is normal in skeletal muscle of type 2 diabetics [64], and exercise also improves insulin sensitivity. For these reasons, exercise is often advised for both the prevention and treatment of insulin resistance. Therefore, understanding the underlying mechanisms regulating glucose uptake is an important area of research.
Insulin signaling
The first step in understanding how glucose uptake is regulated during exercise and how insulin sensitivity is enhanced following exercise is to understand how insulin regulates glucose uptake in normal healthy individuals. In brief, insulin promotes glucose uptake through a signaling cascade consisting of a number of spatially distinct phosphorylation events that result in moving glucose transporters (GLUT4) to the plasma membrane, which upregulates glucose transport into the cell (Fig. 1). Specifically, insulin mediates glucose uptake by binding to its tyrosine kinase receptor on the outside of the cell, causing further activation/phosphorylation of the IRS proteins-1 and 2 inside the cell. Activation of IRS proteins trigger the activation of class I phosphatidlyinositol-3-kinase (PI3K) and subsequent interaction with p110 catalytic and p85 regulatory subunits via increased interaction with SH2 domains, which allows phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) to form phosphatidylinositol 3,4,5-triphosphate (PIP3) at the plasma membrane. This promotes Akt recruitment to the plasma membrane via PH domain interaction with PIP3, which induces a conformational change in Akt that allows phosphorylation at T308 S473 and activation [65]. Interaction with the activating kinase phosphoinositide-dependent kinase (PDK) phosphorylates T308 in the activation loop and leads to partial activation of Akt/protein kinase B (PKB) [66]. The complete activation of Akt requires phosphorylation of Akt at the hydrophobic C-terminal domain S473 residue by mammalian target of rapamycin complex 2 (mTORC2) [67]. Akt phosphorylation of TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 4 (TBC1D4) (formerly known as Akt substrate of 160 kDa; AS160) at T642 and phospho S/T Akt (PAS) sites, with the (R/K)X(R/K)XXS*/T* recognition motif, is important for GLUT4 translocation in response to insulin. Phosphorylation of TBC1D4 increases binding to 14-3-3 proteins [68-70], and this has been proposed to inhibit RabGAP function towards downstream Rabs; thereby, promoting GTP loading and activation of Rabs and the release of glucose transporter GLUT4 from intracellular compartments to the plasma membrane for glucose uptake [69,71-73].
TBC1D4
Correlation studies suggest that T642 (human and T649 in mouse) is the predominant Akt site on TBC1D4 recognized by the PAS antibody [74]. In mice, whole-body mutation of S642 (S649 in mouse) to alanine (TBC1D4 T649A KI) reduces whole-body glucose and insulin intolerance and impairs insulin-stimulated glucose uptake and GLUT4 translocation in muscle [75]. Similarly, overexpression of TBC1D4 by mutation of four predominant Akt phosphorylation sites (S318, S588, T642, and S751) (4P mutant) in mouse skeletal muscle inhibits insulin-stimulated glucose uptake in vivo by ~50% [76]. Interestingly, this defect is rescued by introduction of a mutant inactive Rab/GAP (R/K), suggesting that this domain is essential for insulin-stimulated glucose uptake. In human skeletal muscle, Treebak et al. [77] have shown that using site-specific antibodies against S318, S341, S588, and S751, TBC1D4 phosphorylation is increased following insulin stimulation during a hyperinsulinemic clamp. These studies support that phosphorylation of TBC1D4 and subsequent 14-3-3 binding and deactivation of this RabGAP is important for insulin-stimulated glucose uptake. It has been proposed that AMPK may phosphorylate TBC1D4 at T642 and promote 14-3-3 binding; however, this has not been confirmed in studies using various cell lines (L6 myotubes, 3T3L1 adipocytes) and cell free assays [70,78-80]. TBC1D4 may also play a role in the insulin sensitizing effects of exercise [77], as exercise training has been shown to restore TBC1D4 phosphorylation in skeletal muscle from type 2 diabetics [81].
Akt2 is essential for TBC1D4 T642 and PAS phosphorylation in response to insulin [76]. Akt2 KO mice and siRNA targeted silencing of IRS1 and Akt2 in human myotubes have blunted insulin-stimulated TBC1D4 phosphorylation compared to their homologous counterparts IRS2 and Akt1 and 3 [68,82]. Reduced IRS1 and Akt phosphorylation has previously been considered an important component leading to reduced insulin-stimulated glucose uptake that is associated with insulin resistance. However, recent evidence suggests that low levels of Akt activation are sufficient for maximal GLUT4 translocation in response to insulin [83], and modest reductions in IRS1 do not necessarily translate into impaired insulin action in skeletal muscle, which has been highlighted in IRS1 heterozygous mice [84] and shRNA mediated silencing of IRS1 in vivo that display normal glucose uptake in response to insulin [85]. A further explanation for these observations whereby insulin signaling is normal despite reduced insulin-stimulated glucose uptake is that insulin-stimulated glucose uptake can also occur independently of PKB/Akt signaling [86]. This process still requires PI3K but involves activation of Rac1, a small GTPase protein from the Rho family that promotes glucose uptake by association with actin; thereby promoting actin remodeling [87].
GLUT4 vesicles move along cytoskeletal elements that are directed by GTP-bound (active) Rab-proteins; small G proteins required for membrane trafficking [69]. Actin remodeling is a dynamic multistep process that occurs at the cell surface, and changes in the spatial and temporal arrangement of actin are considered important for providing a scaffold for the transmission of signaling from insulin receptor to GLUT4. Whilst the regulation of actin by Rac1 and the interaction between actin and GLUT4 vesicles in regulating insulin-stimulated glucose uptake has not been extensively studied compared to the Akt/PKB pathway, it is known that that Rac1 is rapidly activated (GTP loaded) in response to insulin in both adipose and muscle cells, and a dominant-negative Rac mutant unable to bind GTP prevents insulin-induced actin remodeling [88]. Evidence that the Rac/actin and PKB are independent pathways both regulating glucose uptake in response to insulin is supported by studies showing that 1) siRNA knockdown of Rac1 in L6 myotubes reduces insulin-stimulated GLUT4 translocation without altering Akt phosphorylation [89]; 2) inhibition of P13K with wortmannin prevents actin remodeling [90] and in contrast, 3) overexpression of a dominant negative Akt mutant does not alter actin remodeling in L6 myotubes [91]. Few studies have investigated the involvement of the Rac/actin pathway in insulin resistance; however, ceramides, which are bioactive lipids that are elevated in obese skeletal muscle and reduce insulin-stimulated glucose uptake, reduce insulin-stimulated actin remodeling and GLUT4 translocation in L6 myotubes [89]. PKC has also been implicated in regulating GLUT4 trafficking to the plasma membrane in response to insulin; however, PKC appears to lie downstream of Rac [92].
TBC1D1
Recently, TBC1D1, a closely related paralog of TBC1D4, has also been identified as an Akt substrate that may play a critical role in regulating GLUT4 trafficking events. TBC1D1 is a candidate gene for the development of severe familial obesity in females, due to the presence of an R125W coding variant that has been identified in 4p15-14-linked obesity pedigrees from American and French populations [93,94]. It is not currently known how the R125W mutation increases susceptibility to obesity; however, it's localization in the phosphotyrosine binding domain of the N-terminus may affect TBC1D1 function [93]. Expression of the R125W mutation in mice reduces insulin-stimulated glucose uptake in skeletal muscle [95]. The C-terminus of TBC1D1 includes a TBC (Tre-2/BUB2/Cdc16) domain that contains Akt, AMPK, and PKA phosphorylation sites thought to be important for regulating Rab GAP activity and association with Rab GPTases; however, the R125W mutation does not affect TBC1D1 PAS phosphorylation [93,95], which suggests that they have distinct functions in regulating glucose uptake. Silencing TBC1D1 in L6 muscle cells by siRNA increases basal and insulin-stimulated GLUT4 translocation [71], and overexpression of TBC1D1 in 3T3-L1 adipocytes with low endogenous TBC1D1 expression inhibits insulin-stimulated GLUT4 translocation, which is reversed by expression of a mutated form of TBC1D1 whereby the GAP domain has been inactivated [96]. Recombinant congenic mice lacking TBC1D1 are protected against diet-induced obesity, which is likely due to increased fatty acid uptake and oxidation in skeletal muscle [97]. These studies support a role for TBC1D1 in regulating glucose uptake.
TBC1D1 and TBC1D4 share 47% sequence identity; however, their GAP domains are 79% identical and 91% similar [96]. Like TBC1D4, TBC1D1 exerts a regulatory role in glucose uptake and metabolism through regulation of its GAP activity. In contrast to TBC1D4, TBC1D1 is only phosphorylated on one of the five standard Akt motifs (T590) and one partial one (S501), which corresponds to T649 and S577 of TBC1D4 in mouse, respectively. The PAS antibody recognizes T590 on TBC1D1, which is the equivalent T642 site on TBC1D4. It has been predicted that this site may also be an AMPK site [74]. Unlike TBC1D4, 14-3-3 binding to TBC1D1 does not occur upon insulin stimulation [70]. TBC1D4 and TBC1D1 also differ in their expression in tissues, whereby TBC1D1 is predominately expressed in skeletal muscle with little in adipose and none in heart whereas TBC1D4 is ubiquitously expressed [98]. Of note, TBC1D4 is predominately expressed in oxidative soleus muscle, whereas TBC1D1 is more highly expressed in glycolytic muscle such as tibialis anterior and extensor digitorum longus [98]. The predominant expression of TBC1D4 in oxidative soleus muscle compared to TBC1D1 may be related to its predominant role in regulating insulin-stimulated glucose uptake, which would be consistent with greater insulin binding capacity of oxidative muscles.
A number of additional Akt phosphorylation sites on TBC1D1 have also been identified (see [99]), and mutation some of these sites (T499, S489, S501, and T590) to alanine in C2C12 myotubes reduces GLUT4 translocation to the cell surface in response to insulin; however, S501 and T590 appear to be the most predominant regulators of TBC1D1 GAP activity controlling this process [99]. Interestingly, the combination of AICAR with insulin is additive in relieving TBC1D1 inhibition on GLUT4 translocation in both wild-type and mutant cells compared to each treatment alone, suggesting a possible role for AMPK in the regulation of TBC1D1 activity [99]. In contrast to the above findings, An et al. [95] has shown that overexpression of TBC1D1 by mutation of four potential AMPK/Akt phosphorylation sites (4P) (S231, T499, T590, S621) in skeletal muscle does not impair insulin-stimulated glucose uptake in vivo, suggesting that alternative AMPK sites may be important or AMPK does not play a role in regulating insulin-stimulated glucose uptake via TBC1D1. In support of this, insulin also does not increase AMPK T172 or ACC S79/212 phosphorylation [74] and AMPK α2, β2 and γ3 null and α2KD and β1β2 M-KO mice have normal insulin-stimulated glucose uptake in muscle [26,28,30,36,100] despite blunted TBC1D1 PAS and T590 phosphorylation in response to insulin [30,74].
Under basal conditions, a role for AMPK in regulating TBC1D1 has been suggested given that 1) the Akt inhibitor wortmannin does not alter basal TBC1D1 phosphorylation [74,101]; 2) Akt2 KO mice have normal basal TBC1D1 phosphorylation [102]; and 3) AMPK α2 KD, α2 KO α2iTg and β1β2 M-KO mice have reduced basal TBC1D1 phosphorylation [30,74,102]. Collectively, these studies suggest that whilst Akt is important for mediating insulin-induced TBC1D1 phosphorylation, AMPK activity is important for maintaining basal levels of T590 phosphorylation. In further support of this, it has been shown that TBC1D1 co-localizes with GLUT4 in response to A-769662 in L6 myotubes [70]. Based on these findings, AMPK may be important for TBC1D1 localization and priming in order to allow phosphorylation by Akt following insulin stimulation. Further investigation on TBC1D1 localization in muscle-specific AMPK β1β2-KO myotubes in response to different stimuli would be of interest for determining this.
Exercise and glucose uptake
Like insulin, exercise increases the rate of glucose uptake into contracting skeletal muscles, by a process regulated by GLUT4 translocation to the plasma membrane and transverse tubules. Interestingly, insulin and exercise/contractions regulate glucose uptake in skeletal muscle by distinct mechanisms (Fig. 2). This revelation came from the following original observations:
1) PI3 kinase inhibitor wortmannin inhibits insulin but not contraction-stimulated glucose uptake. Contraction does not promote IRS-1 autophosphorylation or increase PI3 kinase activity [103-106].
2) Knockout of the predominant insulin signaling proteins IRS1 and Akt2 does not affect contraction-mediated glucose uptake [107,108].
3) Insulin is additive to contraction in stimulating glucose uptake [109,110].
4) Contraction-mediated glucose uptake is maintained in humans and diet and genetic rodent models of insulin resistance [111-114].
TBC1D4
The involvement of TBC1D4 in regulating glucose uptake in response to contraction has been extensively summarized (see review [73]). In brief, evidence that TBC1D4 is involved in contraction-mediated glucose uptake came from the following studies:
1) Rat epitrochlearis muscle contracted in vitro in the absence of insulin increased TBC1D4 phosphorylation [115].
2) Contraction and insulin additively increased TBC1D4 phosphorylation [115].
3) TBC1D4 4P mutant has impaired contraction-mediated glucose uptake [68].
AMPK rather than Akt has been proposed to be a possible candidate regulating TBC1D4 activity in response to exercise and muscle contractions given 1) Akt phosphorylation is not increased by exercise; 2) AICAR stimulates glucose uptake independently of insulin; 3) AICAR increases phosphorylation of TBC1D4 at PAS motifs in both rat [115] and mouse skeletal muscle [76]; and 4) glucose uptake is impaired in the TBC1D4 4P mutant in response to AICAR and contraction [76]. The binding of Ca2+/calmodulin to the Ca2+/calmodulin binding domain (CBD) of TBC1D4 also regulates glucose uptake in response to exercise but not insulin. However, combining the 4P mutant with a CBD mutant results in similar reductions in glucose uptake when compared to the 4P and CBD mutants alone [116], suggesting that each is necessary but not sufficient for regulating this process.
Alternative studies provide evidence that PAS-TBC1D4 phosphorylation is not essential for contraction-mediated glucose uptake given that increases in phosphorylation do not appear at the onset of exercise when glucose uptake is rapidly increased (reviewed in [73]). Consistent with this, TBC1D4 T649A KI mice do not have impaired AICAR and contraction mediated glucose uptake, suggesting that the other three sites (S325, S595, and S758) may also be important for regulating TBC1D4 activity and glucose uptake during exercise [78]. Of note, TBC1D4 PAS phosphorylation is not increased with contraction in TBC1D4 T649A KI mice, supporting that TBC1D4 PAS antibody primarily recognizes the T649 site. Worth mentioning is that the S595 site has also been shown to be a potential AMPK site [80], and indeed, its phosphorylation was increased upon in situ contraction in muscle extracts from both wild-type and TBC1D4 T649A KI mice [78]. Further studies in alternative knockin mutant mice may be important for further defining the role of TBC1D4 in regulating glucose uptake in response to exercise and contraction.
TBC1D1
Like TBC1D4, TBC1D1 is phosphorylated in response to AICAR and muscle contractions/exercise [74,95,101,102,117]. In response to muscle contractions, increases in TBC1D1 phosphorylation are important for 14-3-3 binding, inhibition of GAP domain function and subsequent increases in glucose uptake [95,102]. This is in contrast to TBC1D4 whereby 14-3-3 binding is not considered important for regulating glucose uptake during exercise [78]. AMPK phosphorylates multiple sites on TBC1D1 (S231, S499, T590, S660, S700), and muscle contractions/exercise predominately induces TBC1D1 phosphorylation on S231 in both humans and mice [74,102,117]. TBC1D1 T590 is also predominately phosphorylated in response to muscle contractions [74]; however, this has not been observed in all studies [102]. Interestingly, two separate studies inactivating 4 predicated TBC1D1 phosphorylation sites (4P mutant) results in 25% to 30% reduction in contraction-mediated glucose uptake [95,102]. An et al. [95] mutated conserved Akt site (T596) and 3 predicted AMPK sites (S231, T499, S621) whereas Vichaiwong et al. [102] mutated 4 predicted AMPK sites (S231, S499, S660, S700).
TBC1D1 expression is normal in skeletal muscle from type 2 diabetics [99], suggesting a possible explanation for normal glucose uptake during exercise in these subjects. In contrast, TBC1D1 expression is reduced by ~50% in skeletal muscle of AMPK α2 KO, α2 KD, α2iTg and β1β2 M-KO mice [30,74,102,117], and this may be compensatory for the lack of phosphorylation and inhibition by AMPK, or alternatively, reduced muscle glucose uptake in AMPK β1β2 M-KO mice. TBC1D1 PAS phosphorylation is slightly increased in α2iTg and α2KO mice but unresponsive in AMPK KD and β1β2 M-KO mice following contractions [30,74], suggesting that AMPK is important for PAS phosphorylation in response to contraction. However, the effect of AMPK on regulating glucose uptake during exercise is less clear. AMPK α2 KO and α2 KD and α2iTg mice have normal or only modest reductions in glucose uptake during contractions [4,26,31,32,118-120]. It appears that only when AMPK activity is completely abolished, as in β1β2 M-KO mice, that more dramatic reductions in glucose uptake are observed [30], which are similar to that observed in LKB1-MKO mice [18]. Although TBC1D1 expression or PAS phosphorylation was not assessed in skeletal muscle from β2 or γ3 KO mice, contraction-mediated glucose uptake was also normal [4,28], suggesting that the remaining subunit isoforms (likely contributing to maintained or elevated α1 AMPK activity) was sufficient to allow for normal glucose uptake. In addition to AMPK, the AMPK-related kinase SNARK has also been shown to be important for glucose uptake during contraction of mouse skeletal muscle [121]. Collectively, these studies support a role for AMPK and possibly AMPK-related kinases in regulating glucose uptake during exercise and muscle contractions. Alternative unidentified pathways may also exist and further studies are required to fully define the underlying mechanisms regulating GLUT4 translocation in response to exercise.
Exercise enhances insulin-stimulated glucose uptake, an effect that can persist for hours following an acute bout of exercise. The underlying mechanisms responsible for exercise-induced improvements in insulin sensitivity are not currently known; however, a number of possible candidates have been suggested (including TBC1D4, AMPK, interleukin 6 [IL-6], adiponectin, glycogen synthesis/levels, fiber-type/oxidative capacity). Arias et al. [122], was one of the first to show that TBC1D4 PAS phosphorylation was elevated in rat skeletal muscle following an acute bout of exercise, an effect that persisted for 3 to 4 hours postexercise. These studies lead to the idea that TBC1D4 may be involved in the insulin sensitizing effects of exercise. Since then, studies comparing insulin sensitivity following both in vivo exercise and in vitro contraction of isolated muscles have been performed. These studies have found that whilst TBC1D4 T642 and PAS phosphorylation is increased immediately after exercise and 3 hours postexercise consistent with enhanced insulin-stimulated glucose uptake; following in vitro contractions TBC1D4 phosphorylation had returned to resting levels 3 hours postexercise despite having an additive effect on glucose uptake in response to insulin [123]. It was proposed that circulating factors such as IL-6 may be involved in postinsulin sensitizing effects of exercise; however, TBC1D4 phosphorylation still returned to resting levels even when serum was added to the incubation media or not. These studies indicate that whilst circulating factors may also play a role in the insulin sensitizing effects of in vivo exercise (see IL-6 and adiponectin section); unknown TBC1D4-independent mechanisms are also involved following in vitro contractions. Studies in humans have also revealed similar findings, whereby 60 minutes of leg extension exercise (80% of maximal exercise capacity) increases TBC1D4 phosphorylation on specific sites (S318, S341, S588, and S751) but not PAS or T642 phosphorylation 4 hours post exercise [77]. In this study, Treebak et al. [77] also found that 14-3-3 binding to TBC1D4 in skeletal muscle was not further enhanced by leg exercise when compared to insulin alone despite increased insulin-stimulated glucose uptake following exercise, suggesting that insulin sensitivity following exercise may not involve 14-3-3 binding to TBC1D4. Similarly, Howlett et al. [124] found that although 3 hours of cycling increased 14-3-3 binding to TBC1D4 immediately following exercise, this had returned to baseline despite maintained TBC1D4 phosphorylation 3 hours postexercise. Whilst these studies support a role for TBC1D4 in insulin sensitivity following exercise, it also suggests that alternative mechanisms are also involved.
Unlike TBC1D4, TBC1D1 requires 14-3-3 binding in response to contraction and AICAR but not insulin in both human and rodent skeletal muscle [74,117]. TBC1D1 phosphorylation is enhanced immediately following exercise but returns to basal levels 3-4 and 27 hours post-exercise in rats, suggesting that the involvement of TBC1D1 in the insulin sensitizing effects of exercise are different from that of TBC1D4. Both acute exercise and AICAR activate AMPK and increase insulin sensitivity. These findings have led to the idea that AMPK may be involved in the insulin sensitizing effects of exercise. Phosphorylation of TBC1D1 at S237 appears to be the predominant site phosphorylated by AMPK; however, TBC1D1 PAS phosphorylation does not appear to correlate well with S237 phosphorylation [74]. No studies have assessed the TBC1D1 phosphorylation at specific sites following exercise or investigated insulin sensitivity in TBC1D1 4P mutant, but these studies would provide valuable evidence about the involvement of AMPK and TBC1D1 in the insulin sensitizing effects of exercise.
Glycogen synthesis is increased following exercise and during insulin stimulation, and insulin-stimulated glycogen synthesis is enhanced following exercise. Contraction and insulin promote glycogen synthesis by distinct mechanisms but both involve multisite dephosphorylation and activation of glycogen synthase (GS). In the case of insulin-stimulated glycogen synthesis, insulin signaling thru Akt inactivates GSK3 by phosphorylation at S9 and 21, and this in turn activates GS. In contrast, contraction requires protein phosphatase 1 (PP1) regulatory unit R(GL) to activate GS [125]. GS is phosphorylated on at least nine sites and insulin and contraction dephosphorylates both C- and N terminal sites [126]. Insulin-stimulated glucose transport enhances cellular G6P, which in turn promotes glycogen synthesis. Mutation of the G6P allosteric binding site on GS R582 to alanine (GS R582 KI) in mice reduces glycogen synthesis in response to insulin, suggesting that the G6P allosteric control of GS is also important in controlling glycogen synthesis [127]. Similarly, mutation of two Akt phosphorylation sites on GSK3 (S9 and S21) to alanine prevents inhibition of GSK3 and results in impaired insulin-stimulated glycogen synthesis [128]. In regards to AMPK, the AMPK β subunits contain a central domain, referred to as the carbohydrate-binding motif (CBM) or glycogen-binding domain that allows AMPK to bind to glycogen [129]. This domain is highly conserved between isoforms and across species, ranging from mammals, fruitfly (Drosophila melanogaster), worm (Caenorhabditis elegans), yeast (Saccharomyces cerevisiae), and plants [129]. The CBM is closely related to isoamylase domains found in glycogen and starch branching enzymes [129]. Recently, mutations in the CBM have been shown to prevent glycogen binding and reduce total AMPK activity in cell-free assays [130] and in vivo [131]. Glycogen can also inhibit AMPK, suggesting that AMPK may regulate cellular energy status through glycogen sensing [130].
AMPK regulates glycogen synthesis through phosphorylation of glycogen synthase (GS) at site 2 (S7) [132]. This inhibits enzyme activity in isolated muscles treated with AICAR [133-135]. In liver, GS inactivation by AMPK activators (AICAR and A769662) occurs at S7 phosphorylation site on GS2, which is the liver-specific isoform [136]. Interestingly, AMPK activation by AICAR promotes glucose uptake and increases G6P, which can be used for glycogen synthesis or metabolized through glycolysis to produce ATP [127]. Recently, acute treatment with AICAR was shown to promote glycogen synthesis in skeletal muscle through a G6P-GS dependent pathway; an effect that is blunted in GS R582A KI mice [137]. These studies suggest that GS inhibition by AMPK can be overridden by G6P. LKB1-MKO and AMPK α2 KO, β2 KO and α2 KD mice have lower starting glycogen levels in skeletal muscle [17,138-140], supporting a role for AMPK in glycogen synthesis.
Glycogen synthesis following exercise
It was previously thought that reduced glycogen synthesis in skeletal muscle from type 2 diabetics contributes to reduced insulin-stimulated glucose uptake [141]. Exercise promotes glycogen resynthesis and this may be important for improving insulin sensitivity postexercise. Funai et al. [142] found that refeeding rather than fasting following exercise reduced the enhanced effects of insulin on glucose uptake as well as TBC1D4 T642 and PAS phosphorylation. These studies suggests that whilst increases in insulin-stimulated glucose uptake following exercise may be to allow for enhanced glycogen synthesis, nutritional state can also influence the magnitude of improvements in insulin sensitivity observed following an acute bout of exercise. It has been proposed that glycogen depletion and AMPK activation may play a role in insulin sensitizing effects of exercise given AMPK γ3 KO and α2 KD mice have impaired glycogen resynthesis following exercise [4,31]. However, alternative rodent studies investigating the relationship between AMPK activation, glycogen synthesis and insulin sensitivity under different contraction (contraction length, frequency, and time) and exercise intensity (high [HIT] vs. low [LIT]) protocols have found inconsistent observations. Koshinaka et al. [143] found that whilst AMPK activation increased with exercise intensity, there were not greater improvements in insulin sensitivity when HIT was compared to LIT exercise groups. Similarly, Kim et al. [144] showed that whilst the different contraction protocols altered the level of AMPK activation, there were no differences in the level of improvement in insulin sensitivity. Furthermore, improvements in insulin sensitivity were not consistent with AMPK activation and glycogen depletion [144]. These studies suggest that whilst AMPK may be involved in insulin sensitizing effects of exercise, alternative pathways and measures other than glycogen levels and AMPK activity should be considered when determining the level of exercise-mediated improvements in insulin sensitivity.
IR and IRS
Exercise improves insulin sensitivity and it was originally proposed that this may involve the direct interaction of AMPK with IRS1 [145]. It has been reported that AMPK rapidly phosphorylates IRS1 on S789 in vitro and treatment with AICAR increases IRS1 S789 phosphorylation in mouse C2C12 myotubes, suggesting a possible link between the potentiating effects of exercise on insulin signaling [145]. Alternative studies show that IRS1 S789 phosphorylation is negatively associated with insulin signaling [146-149]. Instead, activation of AMPK by glucose deprivation or AICAR promotes tyrosine phosphorylation of IR and IRS-1 as well as Akt T308 and S473 phosphorylation [146]. Whilst AMPK is not a tyrosine kinase, it is hypothesized that S/T phosphorylation of IR and IRS-1 by AMPK promotes allosteric activation by tyrosine kinases; however, further studies are required to confirm this [146].
mTOR
An alternative mechanism that may explain the potential insulin sensitizing effects of exercise involves AMPK inhibition of the mammalian target of rapamycin/p70 ribosomal S6 kinase (mTOR/p70 S6K) signaling pathway [150]. Obese and type 2 diabetic rodents have increased mTOR/S6K signaling and this may contribute to insulin resistance [151-153]. S6K phosphorylation of IRS1 at S1101 is increased in genetic and diet-induced obese mice and has shown to induce insulin resistance [154]. Inhibition of mTOR/p70 S6K with rapamycin restores insulin sensitivity caused by amino acids in human skeletal muscle [155,156]. Endurance training has been shown to inhibit mTOR/p70 S6K signaling and reduce IRS1 serine phosphorylation in rat skeletal muscle [157], and recent studies have demonstrated that AMPK is involved in the suppression of mTOR signaling [39]. For example treatment with AICAR inhibits S6K (mTOR effector) activity in a range of mammalian cells [150]. Similarly, incubation with AICAR in C2C12 myotubes transfected with an adenovirus of a constitutively active (truncated form of AMPKα1) or KD form of AMPKα revealed that serine phosphorylation of IRS1 was decreased at a target site of mTOR/p70 S6K, which has been associated with insulin resistance [158]. Recently, AMPK was found to phosphorylate the IR in response to glucose deprivation; conditions that also suppresses mTOR activity [146]. The α2 subunit of AMPK is required for AICAR-induced inhibitory effects of mTOR signaling in skeletal muscle [159], which is consistent with alternative findings that showing that under basal conditions the α2 subunit rather than α1 subunit is required for AICAR-induced glucose uptake [26]. Thus, increased AMPK activity could be hypothesized to impair inhibitory mTOR signaling towards IRS1. Further studies are required to establish this.
Adiponectin
The stimulation of AMPK by adiponectin may also be an alternative mechanism by which AMPK improves insulin sensitivity. Recent studies have shown that the activation of AMPK by adiponectin enhances the ability of insulin to stimulate IRS1 and Akt phosphorylation concurrently, with reduced S6K1 phosphorylation at T389 as well as IRS1 phosphorylation at S302 and S636/639 [160]. Aerobic training increases circulating adiponectin and adiponectin receptor mRNA in skeletal muscle [161], further supporting a role for AMPK signaling in improving insulin sensitivity during exercise. JNK and IKK can phosphorylate serine residues on IRS1 and impair insulin signaling; therefore, these studies may suggest that activation of AMPK during exercise may help restore insulin signaling that is impaired by these serine kinases in obesity.
IL-6
The gp130 receptor IL-6 protein was one of the first identified myokines whose production in skeletal muscle and release into the circulation increases almost 100 fold in response to exercise [162]. Circulating IL-6 levels are elevated in obesity and during exercise; however, in obesity high levels of IL-6 have been linked to insulin resistance whereas during exercise IL-6 may enhance glucose uptake via AMPK and improve insulin sensitivity given IL-6 is additive to insulin in promoting glucose uptake. Carey et al. [163] was one of the first studies to show that IL-6 increases glucose disposal in humans and glucose uptake in L6 myotubes; an effect dependent on AMPK signaling. Their study and Geiger et al. [164] also suggested that IL-6 is additive to insulin in stimulating glucose uptake; however, this was not observed by all studies [165] who found that IL-6 regulated glucose uptake and glycogen synthesis via a PI3-dependent pathway and not AMPK; given human myotubes targeted for AMPK depletion by siRNA did not have impaired insulin sensitivity. In contrast, Geiger et al. [164] showed that in whole muscle, which is more biologically relevant, that only higher concentrations of IL-6 increased AMPK phosphorylation; suggesting that under physiological conditions, such as during exercise, IL-6 may play a less significant role in positively regulating metabolic processes. The following year, Nieto-Vazquez et al. [166] found that the differential effects of IL-6 may be due to the amount of exposure to the cytokine, whereby, chronic treatment induces insulin resistance via mechanisms involving protein-tyrosine phosphatase 1B, JNK activation and SOCS3-mediated inhibition of insulin signaling, while acute exposure enhances insulin-stimulated glucose uptake via the LKB1/AMPK/TBC1D4 pathway. Recently, IL-6 KO mice reveal a relatively minor role for IL-6 in promoting glucose clearance during acute treadmill exercise [167]. Postexercise IL-6 levels are positively correlated with exercise duration (reviewed in [168]), and during the recovery period it could be speculated that the effects of IL-6 on metabolism are most pronounced. The majority of the data showing a positive effect of IL-6 on substrate utilization and insulin sensitivity has relied on the infusion of supraphysiological IL-6 concentrations, which does not demonstrate the physiological role of circulating IL-6 during and following exercise. Nonetheless finding from these studies have shown that IL-6 is important for insulin secretion and glucose tolerance via glucagon like peptide 1 (GLP-1) [169]. An alternative study utilizing IL-6 KO mice has shown that IL-6 is required for improving insulin-sensitivity in high-fat fed mice following chronic (4 weeks) voluntary wheel exercise training through lowering serum retinol binding protein 4 (RBP-4) levels [167], which have been implicated in obesity-induced insulin resistance in both humans and rodents [170,171]. Therefore, whilst these studies support a role for IL-6 in improving insulin sensitivity following exercise via RBP-4 and GLP-1, the involvement in AMPK in regulating this process remains to be determined.
Whilst it has been reported that AMPK activity and protein expression may be reduced in obesity [9,172,173], chronic exercise training increases AMPK protein expression and activity [174]. Therefore, AMPK may enhance insulin sensitivity through increasing TBC1D1 and TBC1D4 phosphorylation. Consistent with this idea, studies have also shown that chronic exercise training increases both protein expression and PAS phosphorylation of TBC1D4 in both humans and rats. TBC1D4 phosphorylation (S318, 341, 588, 642, and 751) is reduced in skeletal muscle from obese type 2 diabetics under basal conditions, but can be restored to comparable levels of nondiabetics by 10 weeks of endurance training [81]. Whether similar findings are observed for TBC1D1 is currently not known. Interestingly, a two week dietary intervention to induce weight loss improved insulin sensitivity in obese humans but did not alter TBC1D1 phosphorylation. Instead, the dietary intervention did increase TBC1D1 S231 and 660 but not S700 or PAS phosphorylation in response to exercise [175].
AMPK γ3 expression is reduced following strength training in obese type 2 diabetic humans and endurance training in healthy men [10,49]. Given deletion of the γ3 isoform is associated with impaired glycogen resynthesis following exercise; it is possible that reduced γ3 expression following exercise training is an adaptive response to enhance oxidative capacity and greater preference for lipid oxidation rather than glycogen utilization. It has recently been suggested that increased basal level of AMPK activity is likely due to γ1 associated complexes given γ3 expression is reduced [176].
In conclusion, AMPK plays an important role in regulating glucose uptake during exercise and may be involved in the insulin sensitizing effects of both acute and chronic exercise. A number of possible mechanisms have been proposed to play a role in insulin sensitizing effects of exercise; however, further studies are required to fully define the role of AMPK in mediating these effects. Exercise remains as one of the most cost effective treatments providing endless health benefits including both the prevention and treatment of obesity-induced insulin resistance. Therefore, future studies aimed at identifying the underlying mechanisms involved in the insulin sensitizing effects of exercise are essential for the development of new strategies both pharmacological and nonpharmacological such as exercise that target these diseases.
Acknowledgements
I would like to thank Dr. Gregory R. Steinberg for insightful suggestions on this manuscript.

No potential conflict of interest relevant to this article was reported.

  • 1. Dyck JR, Gao G, Widmer J, Stapleton D, Fernandez CS, Kemp BE, Witters LA. Regulation of 5'-AMP-activated protein kinase activity by the noncatalytic beta and gamma subunits. J Biol Chem 1996;271:17798-17803. PubMed
  • 2. Cheung PC, Salt IP, Davies SP, Hardie DG, Carling D. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J 2000;346 Pt 3:659-669. PubMed
  • 3. Luptak I, Shen M, He H, Hirshman MF, Musi N, Goodyear LJ, Yan J, Wakimoto H, Morita H, Arad M, Seidman CE, Seidman JG, Ingwall JS, Balschi JA, Tian R. Aberrant activation of AMP-activated protein kinase remodels metabolic network in favor of cardiac glycogen storage. J Clin Invest 2007;117:1432-1439. ArticlePubMedPMC
  • 4. Barnes BR, Marklund S, Steiler TL, Walter M, Hjalm G, Amarger V, Mahlapuu M, Leng Y, Johansson C, Galuska D, Lindgren K, Abrink M, Stapleton D, Zierath JR, Andersson L. The 5'-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J Biol Chem 2004;279:38441-38447. PubMed
  • 5. Mahlapuu M, Johansson C, Lindgren K, Hjalm G, Barnes BR, Krook A, Zierath JR, Andersson L, Marklund S. Expression profiling of the gamma-subunit isoforms of AMP-activated protein kinase suggests a major role for gamma3 in white skeletal muscle. Am J Physiol Endocrinol Metab 2004;286:E194-E200. PubMed
  • 6. Yu H, Fujii N, Hirshman MF, Pomerleau JM, Goodyear LJ. Cloning and characterization of mouse 5'-AMP-activated protein kinase gamma3 subunit. Am J Physiol Cell Physiol 2004;286:C283-C292. PubMed
  • 7. Chen Z, Heierhorst J, Mann RJ, Mitchelhill KI, Michell BJ, Witters LA, Lynch GS, Kemp BE, Stapleton D. Expression of the AMP-activated protein kinase beta1 and beta2 subunits in skeletal muscle. FEBS Lett 1999;460:343-348. PubMed
  • 8. Murphy RM. Enhanced technique to measure proteins in single segments of human skeletal muscle fibers: fiber-type dependence of AMPK-alpha1 and -beta1. J Appl Physiol 2011;110:820-825. PubMed
  • 9. Mortensen B, Poulsen P, Wegner L, Stender-Petersen KL, Ribel-Madsen R, Friedrichsen M, Birk JB, Vaag A, Wojtaszewski JF. Genetic and metabolic effects on skeletal muscle AMPK in young and older twins. Am J Physiol Endocrinol Metab 2009;297:E956-E964. ArticlePubMed
  • 10. Wojtaszewski JF, Birk JB, Frosig C, Holten M, Pilegaard H, Dela F. 5'AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes. J Physiol 2005;564(Pt 2):563-573. ArticlePubMedPMC
  • 11. Sanders MJ, Grondin PO, Hegarty BD, Snowden MA, Carling D. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J 2007;403:139-148. ArticlePubMedPMCPDF
  • 12. Oakhill JS, Steel R, Chen ZP, Scott JW, Ling N, Tam S, Kemp BE. AMPK is a direct adenylate charge-regulated protein kinase. Science 2011;332:1433-1435. ArticlePubMed
  • 13. Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV, Carmena D, Jing C, Walker PA, Eccleston JF, Haire LF, Saiu P, Howell SA, Aasland R, Martin SR, Carling D, Gamblin SJ. Structure of mammalian AMPK and its regulation by ADP. Nature 2011;472:230-233. ArticlePubMedPMCPDF
  • 14. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, Hardie DG. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 1996;271:27879-27887. ArticlePubMed
  • 15. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, Hardie DG. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2003;2:28ArticlePubMedPMC
  • 16. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M, Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 2003;13:2004-2008. ArticlePubMed
  • 17. Koh HJ, Arnolds DE, Fujii N, Tran TT, Rogers MJ, Jessen N, Li Y, Liew CW, Ho RC, Hirshman MF, Kulkarni RN, Kahn CR, Goodyear LJ. Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol Cell Biol 2006;26:8217-8227. ArticlePubMedPMCPDF
  • 18. Sakamoto K, McCarthy A, Smith D, Green KA, Grahame Hardie D, Ashworth A, Alessi DR. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J 2005;24:1810-1820. ArticlePubMedPMC
  • 19. Thomson DM, Porter BB, Tall JH, Kim HJ, Barrow JR, Winder WW. Skeletal muscle and heart LKB1 deficiency causes decreased voluntary running and reduced muscle mitochondrial marker enzyme expression in mice. Am J Physiol Endocrinol Metab 2007;292:E196-E202. ArticlePubMed
  • 20. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 2005;280:29060-29066. ArticlePubMed
  • 21. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG, Hardie DG. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2005;2:9-19. PubMed
  • 22. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M, Carling D. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2005;2:21-33. PubMed
  • 23. DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 2009;32(Suppl 2):S157-S163. ArticlePubMedPMCPDF
  • 24. DeFronzo RA, Ferrannini E, Sato Y, Felig P, Wahren J. Synergistic interaction between exercise and insulin on peripheral glucose uptake. J Clin Invest 1981;68:1468-1474. ArticlePubMedPMC
  • 25. Thiebaud D, Jacot E, DeFronzo RA, Maeder E, Jequier E, Felber JP. The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes 1982;31:957-963. ArticlePubMedPDF
  • 26. Jorgensen SB, Viollet B, Andreelli F, Frosig C, Birk JB, Schjerling P, Vaulont S, Richter EA, Wojtaszewski JF. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 2004;279:1070-1079. PubMed
  • 27. Dzamko N, van Denderen BJ, Hevener AL, Jorgensen SB, Honeyman J, Galic S, Chen ZP, Watt MJ, Campbell DJ, Steinberg GR, Kemp BE. AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance. J Biol Chem 2010;285:115-122. PubMed
  • 28. Steinberg GR, O'Neill HM, Dzamko NL, Galic S, Naim T, Koopman R, Jorgensen SB, Honeyman J, Hewitt K, Chen ZP, Schertzer JD, Scott JW, Koentgen F, Lynch GS, Watt MJ, van Denderen BJ, Campbell DJ, Kemp BE. Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity. J Biol Chem 2010;285:37198-37209. PubMedPMC
  • 29. Dasgupta B, Ju JS, Sasaki Y, Liu X, Jung SR, Higashida K, Lindquist D, Milbrandt J. The AMPK beta2 subunit is required for energy homeostasis during metabolic stress. Mol Cell Biol 2012;32:2837-2848. PubMedPMC
  • 30. O'Neill HM, Maarbjerg SJ, Crane JD, Jeppesen J, Jorgensen SB, Schertzer JD, Shyroka O, Kiens B, van Denderen BJ, Tarnopolsky MA, Kemp BE, Richter EA, Steinberg GR. AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc Natl Acad Sci U S A 2011;108:16092-16097. PubMedPMC
  • 31. Mu J, Brozinick JT Jr, Valladares O, Bucan M, Birnbaum MJ. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 2001;7:1085-1094. ArticlePubMed
  • 32. Fujii N, Hirshman MF, Kane EM, Ho RC, Peter LE, Seifert MM, Goodyear LJ. AMP-activated protein kinase alpha2 activity is not essential for contraction- and hyperosmolarity-induced glucose transport in skeletal muscle. J Biol Chem 2005;280:39033-39041. PubMed
  • 33. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Geloen A, Flamez D, Mu J, Lenzner C, Baud O, Bennoun M, Gomas E, Nicolas G, Wojtaszewski JF, Kahn A, Carling D, Schuit FC, Birnbaum MJ, Richter EA, Burcelin R, Vaulont S. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 2003;111:91-98. ArticlePubMedPMC
  • 34. Dzamko N, Schertzer JD, Ryall JG, Steel R, Macaulay SL, Wee S, Chen ZP, Michell BJ, Oakhill JS, Watt MJ, Jorgensen SB, Lynch GS, Kemp BE, Steinberg GR. AMPK-independent pathways regulate skeletal muscle fatty acid oxidation. J Physiol 2008;586:5819-5831. ArticlePubMedPMC
  • 35. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Flamez D, Mu J, Wojtaszewski JF, Schuit FC, Birnbaum M, Richter E, Burcelin R, Vaulont S. Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem Soc Trans 2003;31:216-219. ArticlePubMedPDF
  • 36. Beck Jorgensen S, O'Neill HM, Hewitt K, Kemp BE, Steinberg GR. Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity. Diabetologia 2009;52:2395-2404. ArticlePubMedPDF
  • 37. Fujii N, Ho RC, Manabe Y, Jessen N, Toyoda T, Holland WL, Summers SA, Hirshman MF, Goodyear LJ. Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulin resistance induced by high-fat feeding of mice. Diabetes 2008;57:2958-2966. PubMedPMC
  • 38. Quinn JM, Tam S, Sims NA, Saleh H, McGregor NE, Poulton IJ, Scott JW, Gillespie MT, Kemp BE, van Denderen BJ. Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or function. FASEB J 2010;24:275-285. ArticlePubMedPMCPDF
  • 39. Egan D, Kim J, Shaw RJ, Guan KL. The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR. Autophagy 2011;7:643-644. ArticlePubMed
  • 40. Nilsson EC, Long YC, Martinsson S, Glund S, Garcia-Roves P, Svensson LT, Andersson L, Zierath JR, Mahlapuu M. Opposite transcriptional regulation in skeletal muscle of AMP-activated protein kinase gamma3 R225Q transgenic versus knock-out mice. J Biol Chem 2006;281:7244-7252. PubMed
  • 41. Canto C, Jiang LQ, Deshmukh AS, Mataki C, Coste A, Lagouge M, Zierath JR, Auwerx J. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 2010;11:213-219. ArticlePubMedPMC
  • 42. Costford SR, Kavaslar N, Ahituv N, Chaudhry SN, Schackwitz WS, Dent R, Pennacchio LA, McPherson R, Harper ME. Gain-of-function R225W mutation in human AMPKgamma(3) causing increased glycogen and decreased triglyceride in skeletal muscle. PLoS One 2007;2:e903ArticlePubMedPMC
  • 43. Crawford SA, Costford SR, Aguer C, Thomas SC, deKemp RA, DaSilva JN, Lafontaine D, Kendall M, Dent R, Beanlands RS, McPherson R, Harper ME. Naturally occurring R225W mutation of the gene encoding AMP-activated protein kinase (AMPK)gamma(3) results in increased oxidative capacity and glucose uptake in human primary myotubes. Diabetologia 2010;53:1986-1997. ArticlePubMedPDF
  • 44. Arad M, Benson DW, Perez-Atayde AR, McKenna WJ, Sparks EA, Kanter RJ, McGarry K, Seidman JG, Seidman CE. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 2002;109:357-362. ArticlePubMedPMC
  • 45. Milan D, Jeon JT, Looft C, Amarger V, Robic A, Thelander M, Rogel-Gaillard C, Paul S, Iannuccelli N, Rask L, Ronne H, Lundstrom K, Reinsch N, Gellin J, Kalm E, Roy PL, Chardon P, Andersson L. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science 2000;288:1248-1251. ArticlePubMed
  • 46. Gollob MH, Seger JJ, Gollob TN, Tapscott T, Gonzales O, Bachinski L, Roberts R. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation 2001;104:3030-3033. ArticlePubMed
  • 47. Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS, Ahmad F, Lozado R, Shah G, Fananapazir L, Bachinski LL, Roberts R. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 2001;344:1823-1831. ArticlePubMed
  • 48. Barnes BR, Glund S, Long YC, Hjalm G, Andersson L, Zierath JR. 5'-AMP-activated protein kinase regulates skeletal muscle glycogen content and ergogenics. FASEB J 2005;19:773-779. ArticlePubMedPDF
  • 49. Frosig C, Jorgensen SB, Hardie DG, Richter EA, Wojtaszewski JF. 5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle. Am J Physiol Endocrinol Metab 2004;286:E411-E417. ArticlePubMed
  • 50. Sahlin K, Tonkonogi M, Soderlund K. Energy supply and muscle fatigue in humans. Acta Physiol Scand 1998;162:261-266. ArticlePubMedPDF
  • 51. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ. Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998;47:1369-1373. ArticlePubMed
  • 52. Hutber CA, Hardie DG, Winder WW. Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase. Am J Physiol 1997;272(2 Pt 1):E262-E266. ArticlePubMed
  • 53. Ihlemann J, Ploug T, Hellsten Y, Galbo H. Effect of tension on contraction-induced glucose transport in rat skeletal muscle. Am J Physiol 1999;277(2 Pt 1):E208-E214. ArticlePubMed
  • 54. Rasmussen BB, Hancock CR, Winder WW. Postexercise recovery of skeletal muscle malonyl-CoA, acetyl-CoA carboxylase, and AMP-activated protein kinase. J Appl Physiol 1998;85:1629-1634. ArticlePubMed
  • 55. Rasmussen BB, Winder WW. Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase. J Appl Physiol 1997;83:1104-1109. ArticlePubMed
  • 56. Vavvas D, Apazidis A, Saha AK, Gamble J, Patel A, Kemp BE, Witters LA, Ruderman NB. Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle. J Biol Chem 1997;272:13255-13261. ArticlePubMed
  • 57. Wojtaszewski JF, Nielsen P, Hansen BF, Richter EA, Kiens B. Isoform-specific and exercise intensity-dependent activation of 5'-AMP-activated protein kinase in human skeletal muscle. J Physiol 2000;528 Pt 1:221-226. ArticlePubMedPDF
  • 58. Chen ZP, Stephens TJ, Murthy S, Canny BJ, Hargreaves M, Witters LA, Kemp BE, McConell GK. Effect of exercise intensity on skeletal muscle AMPK signaling in humans. Diabetes 2003;52:2205-2212. ArticlePubMedPDF
  • 59. Fujii N, Hayashi T, Hirshman MF, Smith JT, Habinowski SA, Kaijser L, Mu J, Ljungqvist O, Birnbaum MJ, Witters LA, Thorell A, Goodyear LJ. Exercise induces isoform-specific increase in 5'AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun 2000;273:1150-1155. ArticlePubMed
  • 60. Winder WW, Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol 1996;270(2 Pt 1):E299-E304. ArticlePubMed
  • 61. Winder WW, Wilson HA, Hardie DG, Rasmussen BB, Hutber CA, Call GB, Clayton RD, Conley LM, Yoon S, Zhou B. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J Appl Physiol 1997;82:219-225. ArticlePubMed
  • 62. Chen TC, Hsieh SS. The effects of repeated maximal voluntary isokinetic eccentric exercise on recovery from muscle damage. Res Q Exerc Sport 2000;71:260-266. ArticlePubMed
  • 63. Hayashi T, Hirshman MF, Fujii N, Habinowski SA, Witters LA, Goodyear LJ. Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 2000;49:527-531. ArticlePubMedPDF
  • 64. Kennedy JW, Hirshman MF, Gervino EV, Ocel JV, Forse RA, Hoenig SJ, Aronson D, Goodyear LJ, Horton ES. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 1999;48:1192-1197. ArticlePubMedPDF
  • 65. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 1996;15:6541-6551. ArticlePubMedPMCPDF
  • 66. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 1997;7:261-269. PubMed
  • 67. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005;307:1098-1101. ArticlePubMed
  • 68. Kramer HF, Witczak CA, Taylor EB, Fujii N, Hirshman MF, Goodyear LJ. AS160 regulates insulin- and contraction-stimulated glucose uptake in mouse skeletal muscle. J Biol Chem 2006;281:31478-31485. ArticlePubMed
  • 69. Sano H, Kane S, Sano E, Miinea CP, Asara JM, Lane WS, Garner CW, Lienhard GE. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem 2003;278:14599-14602. ArticlePubMed
  • 70. Chen S, Murphy J, Toth R, Campbell DG, Morrice NA, Mackintosh C. Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. Biochem J 2008;409:449-459. ArticlePubMedPDF
  • 71. Ishikura S, Klip A. Muscle cells engage Rab8A and myosin Vb in insulin-dependent GLUT4 translocation. Am J Physiol Cell Physiol 2008;295:C1016-C1025. ArticlePubMed
  • 72. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001;414:799-806. ArticlePubMedPDF
  • 73. Cartee GD, Funai K. Exercise and insulin: convergence or divergence at AS160 and TBC1D1? Exerc Sport Sci Rev 2009;37:188-195. PubMedPMC
  • 74. Pehmoller C, Treebak JT, Birk JB, Chen S, Mackintosh C, Hardie DG, Richter EA, Wojtaszewski JF. Genetic disruption of AMPK signaling abolishes both contraction- and insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle. Am J Physiol Endocrinol Metab 2009;297:E665-E675. ArticlePubMedPMC
  • 75. Chen S, Wasserman DH, MacKintosh C, Sakamoto K. Mice with AS160/TBC1D4-Thr649Ala knockin mutation are glucose intolerant with reduced insulin sensitivity and altered GLUT4 trafficking. Cell Metab 2011;13:68-79. ArticlePubMedPMC
  • 76. Kramer HF, Witczak CA, Fujii N, Jessen N, Taylor EB, Arnolds DE, Sakamoto K, Hirshman MF, Goodyear LJ. Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes 2006;55:2067-2076. ArticlePubMedPDF
  • 77. Treebak JT, Frosig C, Pehmoller C, Chen S, Maarbjerg SJ, Brandt N, MacKintosh C, Zierath JR, Hardie DG, Kiens B, Richter EA, Pilegaard H, Wojtaszewski JF. Potential role of TBC1D4 in enhanced post-exercise insulin action in human skeletal muscle. Diabetologia 2009;52:891-900. ArticlePubMedPMCPDF
  • 78. Ducommun S, Wang HY, Sakamoto K, Mackintosh C, Chen S. Thr649Ala-AS160 knock-in mutation does not impair contraction/AICAR-induced glucose transport in mouse muscle. Am J Physiol Endocrinol Metab 2012;302:E1036-E1043. ArticlePubMedPMC
  • 79. Chen S, Mackintosh C. Differential regulation of NHE1 phosphorylation and glucose uptake by inhibitors of the ERK pathway and p90RSK in 3T3-L1 adipocytes. Cell Signal 2009;21:1984-1993. ArticlePubMed
  • 80. Geraghty KM, Chen S, Harthill JE, Ibrahim AF, Toth R, Morrice NA, Vandermoere F, Moorhead GB, Hardie DG, MacKintosh C. Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR. Biochem J 2007;407:231-241. ArticlePubMedPMCPDF
  • 81. Vind BF, Pehmoller C, Treebak JT, Birk JB, Hey-Mogensen M, Beck-Nielsen H, Zierath JR, Wojtaszewski JF, Hojlund K. Impaired insulin-induced site-specific phosphorylation of TBC1 domain family, member 4 (TBC1D4) in skeletal muscle of type 2 diabetes patients is restored by endurance exercise-training. Diabetologia 2011;54:157-167. ArticlePubMedPDF
  • 82. Bouzakri K, Zachrisson A, Al-Khalili L, Zhang BB, Koistinen HA, Krook A, Zierath JR. siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab 2006;4:89-96. ArticlePubMed
  • 83. Hoehn KL, Hohnen-Behrens C, Cederberg A, Wu LE, Turner N, Yuasa T, Ebina Y, James DE. IRS1-independent defects define major nodes of insulin resistance. Cell Metab 2008;7:421-433. ArticlePubMedPMC
  • 84. Shirakami A, Toyonaga T, Tsuruzoe K, Shirotani T, Matsumoto K, Yoshizato K, Kawashima J, Hirashima Y, Miyamura N, Kahn CR, Araki E. Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes. J Endocrinol 2002;174:309-319. ArticlePubMed
  • 85. Cleasby ME, Reinten TA, Cooney GJ, James DE, Kraegen EW. Functional studies of Akt isoform specificity in skeletal muscle in vivo: maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression. Mol Endocrinol 2007;21:215-228. ArticlePubMedPDF
  • 86. Gonzalez E, McGraw TE. Insulin signaling diverges into Akt-dependent and -independent signals to regulate the recruitment/docking and the fusion of GLUT4 vesicles to the plasma membrane. Mol Biol Cell 2006;17:4484-4493. ArticlePubMedPMC
  • 87. Zaid H, Antonescu CN, Randhawa VK, Klip A. Insulin action on glucose transporters through molecular switches, tracks and tethers. Biochem J 2008;413:201-215. ArticlePubMedPDF
  • 88. JeBailey L, Rudich A, Huang X, Di Ciano-Oliveira C, Kapus A, Klip A. Skeletal muscle cells and adipocytes differ in their reliance on TC10 and Rac for insulin-induced actin remodeling. Mol Endocrinol 2004;18:359-372. ArticlePubMed
  • 89. JeBailey L, Wanono O, Niu W, Roessler J, Rudich A, Klip A. Ceramide- and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells. Diabetes 2007;56:394-403. ArticlePubMedPDF
  • 90. Tsakiridis T, Vranic M, Klip A. Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitment of glucose transporters to the plasma membrane. J Biol Chem 1994;269:29934-29942. ArticlePubMed
  • 91. Wang Q, Somwar R, Bilan PJ, Liu Z, Jin J, Woodgett JR, Klip A. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol 1999;19:4008-4018. ArticlePubMedPMCPDF
  • 92. Uberall F, Hellbert K, Kampfer S, Maly K, Villunger A, Spitaler M, Mwanjewe J, Baier-Bitterlich G, Baier G, Grunicke HH. Evidence that atypical protein kinase C-lambda and atypical protein kinase C-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton. J Cell Biol 1999;144:413-425. PubMedPMC
  • 93. Stone S, Abkevich V, Russell DL, Riley R, Timms K, Tran T, Trem D, Frank D, Jammulapati S, Neff CD, Iliev D, Gress R, He G, Frech GC, Adams TD, Skolnick MH, Lanchbury JS, Gutin A, Hunt SC, Shattuck D. TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predisposition. Hum Mol Genet 2006;15:2709-2720. ArticlePubMed
  • 94. Meyre D, Farge M, Lecoeur C, Proenca C, Durand E, Allegaert F, Tichet J, Marre M, Balkau B, Weill J, Delplanque J, Froguel P. R125W coding variant in TBC1D1 confers risk for familial obesity and contributes to linkage on chromosome 4p14 in the French population. Hum Mol Genet 2008;17:1798-1802. ArticlePubMed
  • 95. An D, Toyoda T, Taylor EB, Yu H, Fujii N, Hirshman MF, Goodyear LJ. TBC1D1 regulates insulin- and contraction-induced glucose transport in mouse skeletal muscle. Diabetes 2010;59:1358-1365. ArticlePubMedPMCPDF
  • 96. Roach WG, Chavez JA, Miinea CP, Lienhard GE. Substrate specificity and effect on GLUT4 translocation of the Rab GTPase-activating protein Tbc1d1. Biochem J 2007;403:353-358. ArticlePubMedPMCPDF
  • 97. Chadt A, Leicht K, Deshmukh A, Jiang LQ, Scherneck S, Bernhardt U, Dreja T, Vogel H, Schmolz K, Kluge R, Zierath JR, Hultschig C, Hoeben RC, Schurmann A, Joost HG, Al-Hasani H. Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity. Nat Genet 2008;40:1354-1359. ArticlePubMedPDF
  • 98. Taylor EB, An D, Kramer HF, Yu H, Fujii NL, Roeckl KS, Bowles N, Hirshman MF, Xie J, Feener EP, Goodyear LJ. Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle. J Biol Chem 2008;283:9787-9796. ArticlePubMedPMC
  • 99. Peck GR, Chavez JA, Roach WG, Budnik BA, Lane WS, Karlsson HK, Zierath JR, Lienhard GE. Insulin-stimulated phosphorylation of the Rab GTPase-activating protein TBC1D1 regulates GLUT4 translocation. J Biol Chem 2009;284:30016-30023. ArticlePubMedPMC
  • 100. Barnes BR, Zierath JR. Role of AMP: activated protein kinase in the control of glucose homeostasis. Curr Mol Med 2005;5:341-348. ArticlePubMed
  • 101. Funai K, Cartee GD. Inhibition of contraction-stimulated AMP-activated protein kinase inhibits contraction-stimulated increases in PAS-TBC1D1 and glucose transport without altering PAS-AS160 in rat skeletal muscle. Diabetes 2009;58:1096-1104. ArticlePubMedPMCPDF
  • 102. Vichaiwong K, Purohit S, An D, Toyoda T, Jessen N, Hirshman MF, Goodyear LJ. Contraction regulates site-specific phosphorylation of TBC1D1 in skeletal muscle. Biochem J 2010;431:311-320. ArticlePubMedPDF
  • 103. Yeh JI, Gulve EA, Rameh L, Birnbaum MJ. The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport. J Biol Chem 1995;270:2107-2111. PubMed
  • 104. Whitehead JP, Soos MA, Aslesen R, O'Rahilly S, Jensen J. Contraction inhibits insulin-stimulated insulin receptor substrate-1/2-associated phosphoinositide 3-kinase activity, but not protein kinase B activation or glucose uptake, in rat muscle. Biochem J 2000;349(Pt 3):775-781. ArticlePubMedPMCPDF
  • 105. Lund S, Holman GD, Schmitz O, Pedersen O. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci U S A 1995;92:5817-5821. ArticlePubMedPMC
  • 106. Brozinick JT Jr, Birnbaum MJ. Insulin, but not contraction, activates Akt/PKB in isolated rat skeletal muscle. J Biol Chem 1998;273:14679-14682. ArticlePubMed
  • 107. Dumke CL, Wetter AC, Arias EB, Kahn CR, Cartee GD. Absence of insulin receptor substrate-1 expression does not alter GLUT1 or GLUT4 abundance or contraction-stimulated glucose uptake by mouse skeletal muscle. Horm Metab Res 2001;33:696-700. ArticlePubMed
  • 108. Sakamoto K, Arnolds DE, Fujii N, Kramer HF, Hirshman MF, Goodyear LJ. Role of Akt2 in contraction-stimulated cell signaling and glucose uptake in skeletal muscle. Am J Physiol Endocrinol Metab 2006;291:E1031-E1037. ArticlePubMed
  • 109. Constable SH, Favier RJ, Cartee GD, Young DA, Holloszy JO. Muscle glucose transport: interactions of in vitro contractions, insulin, and exercise. J Appl Physiol 1988;64:2329-2332. ArticlePubMed
  • 110. Gao J, Ren J, Gulve EA, Holloszy JO. Additive effect of contractions and insulin on GLUT-4 translocation into the sarcolemma. J Appl Physiol 1994;77:1597-1601. ArticlePubMed
  • 111. Martin IK, Katz A, Wahren J. Splanchnic and muscle metabolism during exercise in NIDDM patients. Am J Physiol 1995;269(3 Pt 1):E583-E590. ArticlePubMed
  • 112. Han X, Ploug T, Galbo H. Effect of diet on insulin- and contraction-mediated glucose transport and uptake in rat muscle. Am J Physiol 1995;269(3 Pt 2):R544-R551. ArticlePubMed
  • 113. King PA, Betts JJ, Horton ED, Horton ES. Exercise, unlike insulin, promotes glucose transporter translocation in obese Zucker rat muscle. Am J Physiol 1993;265(2 Pt 2):R447-R452. ArticlePubMed
  • 114. Brozinick JT Jr, Etgen GJ Jr, Yaspelkis BB 3rd, Ivy JL. Contraction-activated glucose uptake is normal in insulin-resistant muscle of the obese Zucker rat. J Appl Physiol 1992;73:382-387. ArticlePubMed
  • 115. Bruss MD, Arias EB, Lienhard GE, Cartee GD. Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes 2005;54:41-50. ArticlePubMedPDF
  • 116. Kramer HF, Taylor EB, Witczak CA, Fujii N, Hirshman MF, Goodyear LJ. Calmodulin-binding domain of AS160 regulates contraction- but not insulin-stimulated glucose uptake in skeletal muscle. Diabetes 2007;56:2854-2862. ArticlePubMedPDF
  • 117. Frosig C, Pehmoller C, Birk JB, Richter EA, Wojtaszewski JF. Exercise-induced TBC1D1 Ser237 phosphorylation and 14-3-3 protein binding capacity in human skeletal muscle. J Physiol 2010;588(Pt 22):4539-4548. ArticlePubMedPMC
  • 118. Lee-Young RS, Griffee SR, Lynes SE, Bracy DP, Ayala JE, McGuinness OP, Wasserman DH. Skeletal muscle AMP-activated protein kinase is essential for the metabolic response to exercise in vivo. J Biol Chem 2009;284:23925-23934. ArticlePubMedPMC
  • 119. Lefort N, St-Amand E, Morasse S, Cote CH, Marette A. The alpha-subunit of AMPK is essential for submaximal contraction-mediated glucose transport in skeletal muscle in vitro. Am J Physiol Endocrinol Metab 2008;295:E1447-E1454. PubMed
  • 120. Merry TL, Steinberg GR, Lynch GS, McConell GK. Skeletal muscle glucose uptake during contraction is regulated by nitric oxide and ROS independently of AMPK. Am J Physiol Endocrinol Metab 2010;298:E577-E585. ArticlePubMed
  • 121. Koh HJ, Toyoda T, Fujii N, Jung MM, Rathod A, Middelbeek RJ, Lessard SJ, Treebak JT, Tsuchihara K, Esumi H, Richter EA, Wojtaszewski JF, Hirshman MF, Goodyear LJ. Sucrose nonfermenting AMPK-related kinase (SNARK) mediates contraction-stimulated glucose transport in mouse skeletal muscle. Proc Natl Acad Sci U S A 2010;107:15541-15546. ArticlePubMedPMC
  • 122. Arias EB, Kim J, Funai K, Cartee GD. Prior exercise increases phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle. Am J Physiol Endocrinol Metab 2007;292:E1191-E1200. ArticlePubMed
  • 123. Funai K, Schweitzer GG, Castorena CM, Kanzaki M, Cartee GD. In vivo exercise followed by in vitro contraction additively elevates subsequent insulin-stimulated glucose transport by rat skeletal muscle. Am J Physiol Endocrinol Metab 2010;298:E999-1010. ArticlePubMedPMC
  • 124. Howlett KF, Mathews A, Garnham A, Sakamoto K. The effect of exercise and insulin on AS160 phosphorylation and 14-3-3 binding capacity in human skeletal muscle. Am J Physiol Endocrinol Metab 2008;294:E401-E407. ArticlePubMed
  • 125. Aschenbach WG, Suzuki Y, Breeden K, Prats C, Hirshman MF, Dufresne SD, Sakamoto K, Vilardo PG, Steele M, Kim JH, Jing SL, Goodyear LJ, DePaoli-Roach AA. The muscle-specific protein phosphatase PP1G/R(GL)(G(M))is essential for activation of glycogen synthase by exercise. J Biol Chem 2001;276:39959-39967. ArticlePubMed
  • 126. Jensen J, Lai YC. Regulation of muscle glycogen synthase phosphorylation and kinetic properties by insulin, exercise, adrenaline and role in insulin resistance. Arch Physiol Biochem 2009;115:13-21. ArticlePubMed
  • 127. Bouskila M, Hunter RW, Ibrahim AF, Delattre L, Peggie M, van Diepen JA, Voshol PJ, Jensen J, Sakamoto K. Allosteric regulation of glycogen synthase controls glycogen synthesis in muscle. Cell Metab 2010;12:456-466. ArticlePubMed
  • 128. McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R, Alessi DR. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J 2005;24:1571-1583. ArticlePubMedPMC
  • 129. Polekhina G, Gupta A, Michell BJ, van Denderen B, Murthy S, Feil SC, Jennings IG, Campbell DJ, Witters LA, Parker MW, Kemp BE, Stapleton D. AMPK beta subunit targets metabolic stress sensing to glycogen. Curr Biol 2003;13:867-871. PubMed
  • 130. McBride A, Ghilagaber S, Nikolaev A, Hardie DG. The glycogen-binding domain on the AMPK beta subunit allows the kinase to act as a glycogen sensor. Cell Metab 2009;9:23-34. PubMedPMC
  • 131. Bendayan M, Londono I, Kemp BE, Hardie GD, Ruderman N, Prentki M. Association of AMP-activated protein kinase subunits with glycogen particles as revealed in situ by immunoelectron microscopy. J Histochem Cytochem 2009;57:963-971. ArticlePubMedPMCPDF
  • 132. Carling D, Hardie DG. The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase. Biochim Biophys Acta 1989;1012:81-86. ArticlePubMed
  • 133. Miyamoto L, Toyoda T, Hayashi T, Yonemitsu S, Nakano M, Tanaka S, Ebihara K, Masuzaki H, Hosoda K, Ogawa Y, Inoue G, Fushiki T, Nakao K. Effect of acute activation of 5'-AMP-activated protein kinase on glycogen regulation in isolated rat skeletal muscle. J Appl Physiol 2007;102:1007-1013. ArticlePubMed
  • 134. Wojtaszewski JF, Jorgensen SB, Hellsten Y, Hardie DG, Richter EA. Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 2002;51:284-292. ArticlePubMedPDF
  • 135. Jorgensen SB, Nielsen JN, Birk JB, Olsen GS, Viollet B, Andreelli F, Schjerling P, Vaulont S, Hardie DG, Hansen BF, Richter EA, Wojtaszewski JF. The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading. Diabetes 2004;53:3074-3081. PubMed
  • 136. Bultot L, Guigas B, Von Wilamowitz-Moellendorff A, Maisin L, Vertommen D, Hussain N, Beullens M, Guinovart JJ, Foretz M, Viollet B, Sakamoto K, Hue L, Rider MH. AMP-activated protein kinase phosphorylates and inactivates liver glycogen synthase. Biochem J 2012;443:193-203. ArticlePubMedPDF
  • 137. Hunter RW, Treebak JT, Wojtaszewski JF, Sakamoto K. Molecular mechanism by which AMP-activated protein kinase activation promotes glycogen accumulation in muscle. Diabetes 2011;60:766-774. ArticlePubMedPMCPDF
  • 138. Jorgensen SB, Wojtaszewski JF, Viollet B, Andreelli F, Birk JB, Hellsten Y, Schjerling P, Vaulont S, Neufer PD, Richter EA, Pilegaard H. Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle. FASEB J 2005;19:1146-1148. ArticlePubMedPDF
  • 139. Steinberg GR, O'Neill HM, Dzamko NL, Galic S, Naim T, Koopman R, Jorgensen SB, Honeyman J, Hewitt K, Chen ZP, Schertzer JD, Scott JW, Koentgen F, Lynch GS, Watt MJ, van Denderen BJ, Campbell DJ, Kemp BE. Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity. J Biol Chem 2010;285:37198-37209. PubMedPMC
  • 140. Mu J, Barton ER, Birnbaum MJ. Selective suppression of AMP-activated protein kinase in skeletal muscle: update on 'lazy mice'. Biochem Soc Trans 2003;31(Pt 1):236-241. ArticlePubMedPDF
  • 141. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 1990;322:223-228. ArticlePubMed
  • 142. Funai K, Schweitzer GG, Sharma N, Kanzaki M, Cartee GD. Increased AS160 phosphorylation, but not TBC1D1 phosphorylation, with increased postexercise insulin sensitivity in rat skeletal muscle. Am J Physiol Endocrinol Metab 2009;297:E242-E251. ArticlePubMedPMC
  • 143. Koshinaka K, Sano A, Howlett KF, Yamazaki T, Sasaki M, Sakamoto K, Kawanaka K. Effect of high-intensity intermittent swimming on postexercise insulin sensitivity in rat epitrochlearis muscle. Metabolism 2008;57:749-756. ArticlePubMed
  • 144. Kim J, Solis RS, Arias EB, Cartee GD. Postcontraction insulin sensitivity: relationship with contraction protocol, glycogen concentration, and 5' AMP-activated protein kinase phosphorylation. J Appl Physiol 2004;96:575-583. ArticlePubMed
  • 145. Jakobsen SN, Hardie DG, Morrice N, Tornqvist HE. 5'-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J Biol Chem 2001;276:46912-46916. ArticlePubMed
  • 146. Chopra I, Li HF, Wang H, Webster KA. Phosphorylation of the insulin receptor by AMP-activated protein kinase (AMPK) promotes ligand-independent activation of the insulin signalling pathway in rodent muscle. Diabetologia 2012;55:783-794. ArticlePubMedPDF
  • 147. Zakikhani M, Blouin MJ, Piura E, Pollak MN. Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells. Breast Cancer Res Treat 2010;123:271-279. ArticlePubMedPDF
  • 148. Horike N, Takemori H, Katoh Y, Doi J, Min L, Asano T, Sun XJ, Yamamoto H, Kasayama S, Muraoka M, Nonaka Y, Okamoto M. Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2. J Biol Chem 2003;278:18440-18447. ArticlePubMed
  • 149. Qiao LY, Zhande R, Jetton TL, Zhou G, Sun XJ. In vivo phosphorylation of insulin receptor substrate 1 at serine 789 by a novel serine kinase in insulin-resistant rodents. J Biol Chem 2002;277:26530-26539. ArticlePubMed
  • 150. Kimura N, Tokunaga C, Dalal S, Richardson C, Yoshino K, Hara K, Kemp BE, Witters LA, Mimura O, Yonezawa K. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway. Genes Cells 2003;8:65-79. ArticlePubMedPDF
  • 151. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, Thomas G. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004;431:200-205. ArticlePubMedPDF
  • 152. Khamzina L, Veilleux A, Bergeron S, Marette A. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 2005;146:1473-1481. ArticlePubMedPDF
  • 153. Dann SG, Selvaraj A, Thomas G. mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med 2007;13:252-259. ArticlePubMed
  • 154. Tremblay F, Brule S, Hee Um S, Li Y, Masuda K, Roden M, Sun XJ, Krebs M, Polakiewicz RD, Thomas G, Marette A. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient-and obesity-induced insulin resistance. Proc Natl Acad Sci U S A 2007;104:14056-14061. ArticlePubMedPMC
  • 155. Krebs M, Brunmair B, Brehm A, Artwohl M, Szendroedi J, Nowotny P, Roth E, Furnsinn C, Promintzer M, Anderwald C, Bischof M, Roden M. The mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes 2007;56:1600-1607. ArticlePubMedPDF
  • 156. Tremblay F, Krebs M, Dombrowski L, Brehm A, Bernroider E, Roth E, Nowotny P, Waldhausl W, Marette A, Roden M. Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 2005;54:2674-2684. ArticlePubMedPDF
  • 157. Glynn EL, Lujan HL, Kramer VJ, Drummond MJ, DiCarlo SE, Rasmussen BB. A chronic increase in physical activity inhibits fed-state mTOR/S6K1 signaling and reduces IRS-1 serine phosphorylation in rat skeletal muscle. Appl Physiol Nutr Metab 2008;33:93-101. ArticlePubMedPMC
  • 158. Ju JS, Gitcho MA, Casmaer CA, Patil PB, Han DG, Spencer SA, Fisher JS. Potentiation of insulin-stimulated glucose transport by the AMP-activated protein kinase. Am J Physiol Cell Physiol 2007;292:C564-C572. ArticlePubMed
  • 159. Deshmukh AS, Treebak JT, Long YC, Viollet B, Wojtaszewski JF, Zierath JR. Role of adenosine 5'-monophosphate-activated protein kinase subunits in skeletal muscle mammalian target of rapamycin signaling. Mol Endocrinol 2008;22:1105-1112. ArticlePubMedPMC
  • 160. Wang C, Mao X, Wang L, Liu M, Wetzel MD, Guan KL, Dong LQ, Liu F. Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1. J Biol Chem 2007;282:7991-7996. ArticlePubMed
  • 161. Bluher M, Bullen JW Jr, Lee JH, Kralisch S, Fasshauer M, Kloting N, Niebauer J, Schon MR, Williams CJ, Mantzoros CS. Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J Clin Endocrinol Metab 2006;91:2310-2316. ArticlePubMed
  • 162. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 2008;88:1379-1406. ArticlePubMed
  • 163. Carey AL, Steinberg GR, Macaulay SL, Thomas WG, Holmes AG, Ramm G, Prelovsek O, Hohnen-Behrens C, Watt MJ, James DE, Kemp BE, Pedersen BK, Febbraio MA. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 2006;55:2688-2697. ArticlePubMedPDF
  • 164. Geiger PC, Hancock C, Wright DC, Han DH, Holloszy JO. IL-6 increases muscle insulin sensitivity only at superphysiological levels. Am J Physiol Endocrinol Metab 2007;292:E1842-E1846. ArticlePubMed
  • 165. Al-Khalili L, Bouzakri K, Glund S, Lonnqvist F, Koistinen HA, Krook A. Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol 2006;20:3364-3375. ArticlePubMedPDF
  • 166. Nieto-Vazquez I, Fernandez-Veledo S, de Alvaro C, Lorenzo M. Dual role of interleukin-6 in regulating insulin sensitivity in murine skeletal muscle. Diabetes 2008;57:3211-3221. ArticlePubMedPMCPDF
  • 167. Benrick A, Wallenius V, Asterholm IW. Interleukin-6 mediates exercise-induced increase in insulin sensitivity in mice. Exp Physiol 2012;97:1224-1235. ArticlePubMedPDF
  • 168. Fischer CP. Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev 2006;12:6-33. PubMed
  • 169. Ellingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, Meier DT, Eppler E, Bouzakri K, Wueest S, Muller YD, Hansen AM, Reinecke M, Konrad D, Gassmann M, Reimann F, Halban PA, Gromada J, Drucker DJ, Gribble FM, Ehses JA, Donath MY. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 2011;17:1481-1489. ArticlePubMedPMCPDF
  • 170. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-2563. ArticlePubMed
  • 171. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-362. ArticlePubMedPDF
  • 172. Lee-Young RS, Ayala JE, Fueger PT, Mayes WH, Kang L, Wasserman DH. Obesity impairs skeletal muscle AMPK signaling during exercise: role of AMPKalpha2 in the regulation of exercise capacity in vivo. Int J Obes (Lond) 2011;35:982-989. PubMed
  • 173. Steinberg GR, Smith AC, Van Denderen BJ, Chen Z, Murthy S, Campbell DJ, Heigenhauser GJ, Dyck DJ, Kemp BE. AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females. J Clin Endocrinol Metab 2004;89:4575-4580. ArticlePubMed
  • 174. Lee-Young RS, Canny BJ, Myers DE, McConell GK. AMPK activation is fiber type specific in human skeletal muscle: effects of exercise and short-term exercise training. J Appl Physiol 2009;107:283-289. ArticlePubMed
  • 175. Jessen N, An D, Lihn AS, Nygren J, Hirshman MF, Thorell A, Goodyear LJ. Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 2011;301:E164-E171. ArticlePubMedPMC
  • 176. Friedrichsen M, Mortensen B, Pehmøller C, Birk JB, Wojtaszewski JF. Exercise-induced AMPK activity in skeletal muscle: role in glucose uptake and insulin sensitivity. Mol Cell Endocrinol Epub 2012 Jul 11. DOI: http://dx.doi.org/10.1016/j.mce.2012.06.013.Article
Fig. 1
Regulation of insulin-stimulated glucose uptake and glycogen synthesis. Insulin stimulates glucose uptake by binding to the insulin receptor (IR), this promotes autophosphorylation and subsequent activation of insulin receptor substrate 1 (IRS1) and PI3 kinase via SH2 interaction with regulatory p85 and catalytic p110 subunits. This promotes association with phosphatidylinositol 4,5-bisphosphate (PIP2) at the plasma membrane, which is converted to phosphatidylinositol 3,4,5-triphosphate (PIP3), which induces a conformational change in Akt that allows Akt phosphorylation and subsequent phosphorylation and inhibition of the Rab-GAP activating protein tre-2/USP6, BUB2, cdc16 domain family member 4 (TBC1D4). Rac/actin can also promote glucose uptake by promoting actin remodeling. Once glucose enters the cell it can be metabolized through glycolysis to produce ATP or utilized for glycogen synthesis. Glycogen synthesis involves phosphorylation and inhibition of glycogen synthase kinase 3 (GSK3) by Akt, which activates glycogen synthase (GS); promoting the conversion of glucose-6 phosphate (G6P) to G1P then uridine diphosphoglucose (UDP-G), which is targeted towards glycogen. AMPK can phosphorylate and inhibit GS; however, G6P can override this inhibitory effect. PTG, protein targeting to glycogen.
dmj-37-1-g001.jpg
Fig. 2
Regulation of glucose uptake during exercise and muscle contractions. During contraction, there is depolarization of T-tubules (plasma membrane only found in skeletal muscle) that causes calcium (Ca2+) release from the sarcoplasmic reticulum, which triggers actin and myosin interaction (red; thick myosin and thin actin filaments). The energy demand of contraction increases the ratio of adenosine monophosphate (AMP)/adenosine triphosphate (ATP), which stimulates AMP-associated protein kinase (AMPK). Both tre-2/USP6, BUB2, cdc16 domain family member 4 and 1 (TBC1D 4 and 1) are involved in regulating glucose uptake in response to contraction; however, it has recently been discovered that TBC1D1 plays a more pivotal role. AMPK can phosphorylate both TBC1D4 and TBC1D1; however, recent studies have shown that during contraction there is a strong correlation between AMPK phosphorylation of TBC1D1 and 14-3-3 binding (proteins that are proposed to be important for regulation of GAP function of TBC1D1 upon phosphorylation), which allows dissociation of Rab proteins and glucose transporter 4 (GLUT4) translocation to the plasma membrane and glucose uptake. AK, adenylate kinase, the enzyme required for generation of AMP.
dmj-37-1-g002.jpg
Table 1
AMPK isoform heterotrimer distribution in mouse glycolytic extensor digitorum longus (EDL) and oxidative soleus muscle
dmj-37-1-i001.jpg

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPARα in the liver and muscles of high fat diet-fed rats
      Zakiah N. Almohawes, Attalla El-Kott, Kareem Morsy, Ali A. Shati, Ayman E. El-Kenawy, Heba S. Khalifa, Fahmy G. Elsaid, Abd-El-Karim M. Abd-Lateif, Ahmed Abu-Zaiton, Eman R. Ebealy, Mohamed M. Abdel-Daim, Reham A. Ghanem, Eman M. Abd-Ella
      Archives of Physiology and Biochemistry.2024; 130(3): 257.     CrossRef
    • Molecular mechanisms underlying sarcopenia in heart failure
      Cody A. Rutledge
      The Journal of Cardiovascular Aging.2024;[Epub]     CrossRef
    • Diarrhea induced by insufficient fat absorption in weaned piglets: Causes and nutrition regulation
      Yuying Li, Pengjun Shi, Kang Yao, Qian Lin, Mansheng Wang, Zhenping Hou, Wenjie Tang, Hui Diao
      Animal Nutrition.2024; 16: 299.     CrossRef
    • Metabolic Reprogramming of Anti-cancer T Cells: Targeting AMPK and PPAR to Optimize Cancer Immunotherapy
      Abduldaheem Turki Jalil, Hassan Hadi Al-Kazzaz, Firas A. Hassan, Safaa Halool Mohammed, Muna S. Merza, Tahani Aslandook, Ahmed Elewadi, Ali Fadhil, Ali Alsalamy
      Indian Journal of Clinical Biochemistry.2024;[Epub]     CrossRef
    • Small peptides: could they have a big role in metabolism and the response to exercise?
      Muhammed M. Atakan, İbrahim Türkel, Berkay Özerkliğ, Şükran N. Koşar, Dale F. Taylor, Xu Yan, David J. Bishop
      The Journal of Physiology.2024; 602(4): 545.     CrossRef
    • The genetic and dietary landscape of the muscle insulin signalling network
      Julian van Gerwen, Stewart WC Masson, Harry B Cutler, Alexis Diaz Vegas, Meg Potter, Jacqueline Stöckli, Søren Madsen, Marin E Nelson, Sean J Humphrey, David E James
      eLife.2024;[Epub]     CrossRef
    • Endurance exercise preconditioning alleviates ferroptosis induced by doxorubicin-induced cardiotoxicity through mitochondrial superoxide-dependent AMPKα2 activation
      Liang Wang, Yang Qiao, Jingzhi Yu, Qihao Wang, Xinyu Wu, Qiqi Cao, Zeyu Zhang, Zhen Feng, Huan He
      Redox Biology.2024; 70: 103079.     CrossRef
    • The genetic and dietary landscape of the muscle insulin signalling network
      Julian van Gerwen, Stewart WC Masson, Harry B Cutler, Alexis Diaz Vegas, Meg Potter, Jacqueline Stöckli, Søren Madsen, Marin E Nelson, Sean J Humphrey, David E James
      eLife.2024;[Epub]     CrossRef
    • AMPK activation modulates IL‐36‐induced inflammatory responses by regulating IκBζ expression in the skin
      Yi‐Ting Huang, Ling‐Ya Chiu, Po‐Hsuan Lu, Pa‐Fan Hsiao, Jen‐Yu Wang, Ping‐Hsun Lu, Nan‐Lin Wu
      British Journal of Pharmacology.2024;[Epub]     CrossRef
    • Harmine alleviated STZ-induced rat diabetic nephropathy: A potential role via regulating AMPK/Nrf2 pathway and deactivating ataxia-telangiectasia mutated (ATM) signaling
      Manar Mohammed El Tabaa, Maram Mohammed El Tabaa, Eman Rashad, Mohammed Salah Elballal, Ola Elazazy
      International Immunopharmacology.2024; 132: 111954.     CrossRef
    • Exercise-Mediated Protection against Air Pollution-Induced Immune Damage: Mechanisms, Challenges, and Future Directions
      Xingsheng Jin, Yang Chen, Bingxiang Xu, Haili Tian
      Biology.2024; 13(4): 247.     CrossRef
    • The beneficial effects of metformin inclusion on growth performance, glucose utilization, antioxidant capacity and apoptosis of largemouth bass (Micropterus salmoides) fed with high dietary carbohydrates
      Xiaoyuan Wang, Ye Gong, Wenfei Li, Ning Liu, Zishuo Fang, Nihe Zhang, Naisong Chen, Songlin Li
      Aquaculture.2024; 588: 740957.     CrossRef
    • Anthracycline Cardiotoxicity Induces Progressive Changes in Myocardial Metabolism and Mitochondrial Quality Control
      Anabel Díaz-Guerra, Rocío Villena-Gutiérrez, Agustín Clemente-Moragón, Mónica Gómez, Eduardo Oliver, Miguel Fernández-Tocino, Carlos Galán-Arriola, Laura Cádiz, Borja Ibáñez
      JACC: CardioOncology.2024; 6(2): 217.     CrossRef
    • Potentilla fulgens upregulate GLUT4, AMPK, AKT and insulin in alloxan-induced diabetic mice: an in vivo and in silico study
      Daiahun Thabah, Donkupar Syiem, Careen Liza Pakyntein, Sagnik Banerjee, Cynthia Erica Kharshiing, Atanu Bhattacharjee
      Archives of Physiology and Biochemistry.2023; 129(5): 1071.     CrossRef
    • The importance of AMPK in obesity and chronic diseases and the relationship of AMPK with nutrition: a literature review
      Eren Canbolat, Funda Pınar Cakıroglu
      Critical Reviews in Food Science and Nutrition.2023; 63(4): 449.     CrossRef
    • Hydrogen Sulfide Regulates Glucose Uptake in Skeletal Muscles via S-Sulfhydration of AMPK in Muscle Fiber Type-Dependent Way
      Kelin Li, Minghui Wang, Ruxia Wang, Xiaojuan Wang, Hongchao Jiao, Jingpeng Zhao, Yunlei Zhou, Haifang Li, Hai Lin
      The Journal of Nutrition.2023; 153(10): 2878.     CrossRef
    • Cellular and Molecular Regulation of Exercise—A Neuronal Perspective
      Ishitha Reddy, Yamini Yadav, Chinmoy Sankar Dey
      Cellular and Molecular Neurobiology.2023; 43(4): 1551.     CrossRef
    • Gene expression profile analysis unravelled the systems level association of renal cell carcinoma with diabetic nephropathy and Matrix-metalloproteinase-9 as a potential therapeutic target
      Aditya Rao, Pavan Gollapalli, Nandini Prasad Shetty
      Journal of Biomolecular Structure and Dynamics.2023; 41(16): 7535.     CrossRef
    • Insulin-mimetic activity of 23-glycosyl oleanane triterpenoids isolated from Gymnema latifolium
      Ha-Thanh-Tung Pham, Eun-Jin Park, Byeol Ryu, Hee-Ju Lee, Thi-Phuong Doan, Hyo-Moon Cho, Thi-Linh-Giang Pham, Won-Keun Oh
      Phytochemistry.2023; 205: 113513.     CrossRef
    • The combination of exercise and metformin inhibits TGF-β1/Smad pathway to attenuate myocardial fibrosis in db/db mice by reducing NF-κB–mediated inflammatory response
      Jingjing Liu, Jiao Lu, Liumei Zhang, Yuting Liu, Yuan Zhang, Yaran Gao, Xinmeng Yuan, Mengqi Xiang, Qiang Tang
      Biomedicine & Pharmacotherapy.2023; 157: 114080.     CrossRef
    • Recent advances in sea cucumber peptide: Production, bioactive properties, and prospects
      Jiacong Man, A. M. Abd El‐Aty, Zuzhe Wang, Mingqian Tan
      Food Frontiers.2023; 4(1): 131.     CrossRef
    • Betulinic Acid: Triterpenoid Derivative Induced NADPH-d Expression in the Urinary System with a Possible Renal Protective Role of Nitric Oxide
      Soo Yue Yin, Siddiqua Ayesha, Chellasamy Panneerselvam, Adel Ibrahim Alalawy, Fahad Mohamed Almutairi, Mohamed Ali Seyed
      Drugs and Drug Candidates.2023; 2(1): 52.     CrossRef
    • Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
      Yi Zhang, Fang Zhou, Jiaheng Guan, Lukun Zhou, Baoan Chen
      Biomolecules.2023; 13(2): 250.     CrossRef
    • The Protective Effect of 11-Keto-β-Boswellic Acid against Diabetic Cardiomyopathy in Rats Entails Activation of AMPK
      Jozaa Z. AlTamimi, Nora A. AlFaris, Ghedeir M. Alshammari, Reham I. Alagal, Dalal H. Aljabryn, Mohammed Abdo Yahya
      Nutrients.2023; 15(7): 1660.     CrossRef
    • Modulation of GPC-4 and GPLD1 serum levels by improving glycemic indices in type 2 diabetes: Resistance training and hawthorn extract intervention
      Ali Heidarianpour, Maryam Keshvari, Siamak Shahidi, Mohammad Zarei
      Heliyon.2023; 9(4): e15537.     CrossRef
    • Oral administration of wild plant‐derived minerals and red ginseng ameliorates insulin resistance in fish through different pathways
      Kiyomi Takase, Izuru Kakuta
      Physiological Reports.2023;[Epub]     CrossRef
    • Anti‐fatigue properties of the ethanol extract of Moringa oleifera leaves in mice
      Xiangyu Bian, Yawen Wang, Renren Yang, Yuying Ma, Weiyun Dong, Changjiang Guo, Weina Gao
      Journal of the Science of Food and Agriculture.2023; 103(11): 5500.     CrossRef
    • AMP-activated protein kinase: An energy sensor and survival mechanism in the reinstatement of metabolic homeostasis
      Ankita Sharma, Sumit Kr Anand, Neha Singh, Upendra Nath Dwivedi, Poonam Kakkar
      Experimental Cell Research.2023; 428(1): 113614.     CrossRef
    • Alternative glucose uptake mediated by β-catenin/RSK1 axis under stress stimuli in mammalian cells
      Caizhu Wang, Ruqin Lin, Xueying Qi, Qiang Xu, Xingsheng Sun, Yurong Zhao, Tianqing Jiang, Jun Jiang, Yu Sun, Yiqun Deng, Jikai Wen
      Biochemical Pharmacology.2023; 214: 115645.     CrossRef
    • Gαi‐coupled GPR41 activation increases Ca2+ influx in C2C12 cells and shows a therapeutic effect in diabetic animals
      Do‐Hyung Lee, Kyung‐Sun Heo, Chang‐Seon Myung
      Obesity.2023; 31(7): 1871.     CrossRef
    • Sapogeninas de Chenopodium quinoa Willd como activadores potenciales de AMPKβ2 para la homeostasis independiente de insulina
      Ricardo Enrique Grados Torrez, Dayana Pamela Bello- Kopa, Ricardo Enrique Grados-Torrez
      Gaceta Médica Boliviana.2023; 46(1): 6.     CrossRef
    • Potential mechanisms of multimodal prehabilitation effects on surgical complications: a narrative review
      Daniel Sibley, Maggie Chen, Malcolm A West, Andrew G Matthew, Daniel Santa Mina, Ian Randall
      Applied Physiology, Nutrition, and Metabolism.2023; 48(9): 639.     CrossRef
    • Insights into the molecular mechanism of muscle textural quality improvement treated by exercise using comparative transcriptome analysis on the hybrid (Erythroculter ilishaeformis ♀ × Ancherythroculter nigrocauda ♂)
      Lang Zhang, Huijie Wei, Yali Yu, Qing Li, Ziwei Song, Yanhong Sun, Pei Li, Jian Chen, Jinhua Gan, Hui Zhang, Xiaorong Lu, Guiying Wang, Li He
      Aquaculture Reports.2023; 31: 101672.     CrossRef
    • Risks and benefits of salicylates in food: a narrative review
      Joanna Suliburska, Rafsan Syabani Cholik
      Nutrition Reviews.2023;[Epub]     CrossRef
    • Nrf2 modulates the benefits of evening exercise in type 2 diabetes
      Babatunde Fasipe, Ismail Laher
      Sports Medicine and Health Science.2023; 5(4): 251.     CrossRef
    • Effectiveness of Combined Aerobic and Resistance Exercise on Cognition, Metabolic Health, Physical Function, and Health-related Quality of Life in Middle-aged and Older Adults With Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
      Jinghua Zhang, Wilson Wai San Tam, Kanokwan Hounsri, Joji Kusuyama, Vivien Xi Wu
      Archives of Physical Medicine and Rehabilitation.2023;[Epub]     CrossRef
    • Early postnatal overnutrition impairs VO2max gains with moderate exercise and increase post-exercise muscle damage in adult male rats
      Douglas Lopes Almeida, Gabriel Sergio Fabricio, Laize Peron Tófolo, Tatiane Aparecida Ribeiro, Camila Cristina Ianoni Matiusso, Maiara Vanusa Guedes Ribeiro, Anna Rebeka Oliveira Ferreira, Audrei Pavanello, Ananda Malta, Kesia Palma-Rigo, Paulo Cezar de F
      Journal of Developmental Origins of Health and Disease.2022; 13(3): 406.     CrossRef
    • Long-term running exercise alleviates cognitive dysfunction in APP/PSEN1 transgenic mice via enhancing brain lysosomal function
      Xue Wang, Yu-ting Zhu, Yi Zhu, Yan-ling Sun, Jun Huang, Zhe Li, Yan Wang, Jun-chao Wu, Zheng-hong Qin, Fang Lin
      Acta Pharmacologica Sinica.2022; 43(4): 850.     CrossRef
    • The Molecular Signature of High-intensity Training in the Human Body
      Patrick Wahl, Wilhelm Bloch, Sebastian Proschinger
      International Journal of Sports Medicine.2022; 43(03): 195.     CrossRef
    • Recent development and advances in the fabrication and biomedical applications of nanoparticle-based drug delivery systems for metformin
      Xiaowei Yang, Qi Lai, Xinmin Yang, Banglin Xie, Bin Zhang, Xiaoyong Zhang, Yen Wei
      Materials Chemistry Frontiers.2022; 6(2): 128.     CrossRef
    • Divergent Effect of Central Incretin Receptors Inhibition in a Rat Model of Sporadic Alzheimer’s Disease
      Jelena Osmanovic Barilar, Ana Knezovic, Jan Homolak, Ana Babic Perhoc, Melita Salkovic-Petrisic
      International Journal of Molecular Sciences.2022; 23(1): 548.     CrossRef
    • The Effect of Various Training on the Expression of the 5’amp-Activated Protein Kinase Α2 and Glucose Transporter - 4 in Type-2 Diabetes Mellitus Rat
      Rahmi Rahmi, Yetty Machrina, Zulham Yamamoto
      Open Access Macedonian Journal of Medical Sciences.2022; 10(A): 1.     CrossRef
    • Avian Orexin: Feed Intake Regulator or Something Else?
      Alison Ramser, Sami Dridi
      Veterinary Sciences.2022; 9(3): 112.     CrossRef
    • Luteolin Synergistically Enhances Antitumor Activity of Oxaliplatin in Colorectal Carcinoma via AMPK Inhibition
      Chan Ho Jang, Nayoung Moon, Jinkyung Lee, Min Jeong Kwon, Jisun Oh, Jong-Sang Kim
      Antioxidants.2022; 11(4): 626.     CrossRef
    • Disrupting AMPK-Glycogen Binding in Mice Increases Carbohydrate Utilization and Reduces Exercise Capacity
      Natalie R. Janzen, Jamie Whitfield, Lisa Murray-Segal, Bruce E. Kemp, John A. Hawley, Nolan J. Hoffman
      Frontiers in Physiology.2022;[Epub]     CrossRef
    • Structure–Activity Relationship of Synthetic Ginkgolic Acid Analogs for Treating Type 2 Diabetes by PTPN9 Inhibition
      Jinsoo Kim, Jinyoung Son, Dohee Ahn, Gibeom Nam, Xiaodi Zhao, Hyuna Park, Woojoo Jeong, Sang J. Chung
      International Journal of Molecular Sciences.2022; 23(7): 3927.     CrossRef
    • Effect of Long-Term Supplementation with Acetic Acid on the Skeletal Muscle of Aging Sprague Dawley Rats
      Hitomi Maruta, Reina Abe, Hiromi Yamashita
      International Journal of Molecular Sciences.2022; 23(9): 4691.     CrossRef
    • AMP activated kinase negatively regulates hepatic Fetuin-A via p38 MAPK-C/EBPβ/E3 Ubiquitin Ligase Signaling pathway
      Vishal Kothari, Jeganathan Ramesh Babu, Suresh T. Mathews, Regis Moreau
      PLOS ONE.2022; 17(5): e0266472.     CrossRef
    • Lariciresinol Displays Anti‐Diabetic Activity through Inhibition of α‐Glucosidase and Activation and Enhancement of Insulin Signaling
      Md Badrul Alam, Jeong‐Sic Ra, Ji‐Young Lim, Bo‐Rim Song, Ahsan Javed, Sang‐Han Lee
      Molecular Nutrition & Food Research.2022;[Epub]     CrossRef
    • Characterizing skeletal muscle dysfunction in women with polycystic ovary syndrome
      Tara McDonnell, Leanne Cussen, Marie McIlroy, Michael W. O’Reilly
      Therapeutic Advances in Endocrinology and Metabolism.2022; 13: 204201882211131.     CrossRef
    • Anti-diabetic and anti-hyperlipidemic effects of sea cucumber (Cucumaria frondosa) gonad hydrolysates in type II diabetic rats
      Tingting Wang, Lin Zheng, Shuguang Wang, Mouming Zhao, Xiaoling Liu
      Food Science and Human Wellness.2022; 11(6): 1614.     CrossRef
    • Hernandezine, a natural herbal alkaloid, ameliorates type 2 diabetes by activating AMPK in two mouse models
      Jing Bai, Shuai Zhang, Jinjing Cao, Hongbin Sun, Zhiguo Mang, Wei L. Shen, Hao Li
      Phytomedicine.2022; 105: 154366.     CrossRef
    • N-Octyl Caffeamide, a Caffeic Acid Amide Derivative, Prevents Progression of Diabetes and Hepatic Steatosis in High-Fat Diet Induced Obese Mice
      Miao-Yi Wu, Chia-Chu Liu, Su-Chu Lee, Yueh-Hsiung Kuo, Tusty-Jiuan Hsieh
      International Journal of Molecular Sciences.2022; 23(16): 8948.     CrossRef
    • The Potential Therapeutic Role of Metformin in Diabetic and Non-Diabetic Bone Impairment
      Wei Mu, Guoqiang Liang, Yue Feng, Yunyun Jiang, Falin Qu
      Pharmaceuticals.2022; 15(10): 1274.     CrossRef
    • Characteristics of the Protocols Used in Electrical Pulse Stimulation of Cultured Cells for Mimicking In Vivo Exercise: A Systematic Review, Meta-Analysis, and Meta-Regression
      Eleni Nintou, Eleni Karligiotou, Maria Vliora, Leonidas G. Ioannou, Andreas D. Flouris
      International Journal of Molecular Sciences.2022; 23(21): 13446.     CrossRef
    • Heliciopsides A−E, Unusual Macrocyclic and Phenolic Glycosides from the Leaves of Heliciopsis terminalis and Their Stimulation of Glucose Uptake
      Byeol Ryu, Eun-Jin Park, Thi-Phuong Doan, Hyo-Moon Cho, Jin-Pyo An, Thi-Linh-Giang Pham, Ha-Thanh-Tung Pham, Won-Keun Oh
      Pharmaceuticals.2022; 15(11): 1315.     CrossRef
    • Why are physical activity breaks more effective than a single session of isoenergetic exercise in reducing postprandial glucose? A systemic review and meta-analysis
      Hannah Gouldrup, Tongyu Ma
      Journal of Sports Sciences.2021; 39(2): 212.     CrossRef
    • TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation
      Hee-Seon Park, Ji-Won Song, Jin-Ho Park, Byung-Kwan Lim, Og-Sung Moon, Hwa-Young Son, Jae-Hyuk Lee, Bin Gao, Young-Suk Won, Hyo-Jung Kwon
      Autophagy.2021; 17(9): 2549.     CrossRef
    • Dissecting the molecular pathways involved in the effects of physical activity on breast cancers cells: A narrative review
      Francesca Maria Orlandella, Anna Elisa De Stefano, Paola Lucia Chiara Iervolino, Pasqualina Buono, Andrea Soricelli, Giuliana Salvatore
      Life Sciences.2021; 265: 118790.     CrossRef
    • In silico study to quantify the effect of exercise on surface GLUT4 translocation in diabetes management
      Darshna M. Joshi, Jignesh Patel, Hardik Bhatt
      Network Modeling Analysis in Health Informatics and Bioinformatics.2021;[Epub]     CrossRef
    • Rationale for the use of metformin and exercise to counteract statin‐associated side effects
      Jonida Haxhi, Paul D. Thompson
      International Journal of Clinical Practice.2021;[Epub]     CrossRef
    • Effects of long-term taurine supplementation on age-related changes in skeletal muscle function of Sprague–Dawley rats
      Yun Ma, Hitomi Maruta, Baojun Sun, Chengduo Wang, Chiaki Isono, Hiromi Yamashita
      Amino Acids.2021; 53(2): 159.     CrossRef
    • The Effect of Swimming Training and Cinnamon Consumption on the Gene Expression of GLUT4 and Insulin Receptor in the Brown Adipose Tissue of Diabetic Rats
      Mojtaba Karimi Fard, Ali Khajehlandi, Amin Mohammadi
      Gene, Cell and Tissue.2021;[Epub]     CrossRef
    • Antiobesity effect of Brassica juncea cultivated in Jeongseon with optimized sinigrin content using 3T3‐L1 adipocytes
      Hee‐Yeon Kwon, Sun‐Il Choi, Xionggao Han, Xiao Men, Gill‐Woong Jang, Ye‐Eun Choi, Ok‐Hwan Lee
      Journal of Food Biochemistry.2021;[Epub]     CrossRef
    • Physicochemical characterization and the hypoglycemia effects of polysaccharide isolated from Passiflora edulis Sims peel
      Yuan Guan, Hefei Sun, Huiying Chen, Peijun Li, Yang Shan, Xia Li
      Food & Function.2021; 12(9): 4221.     CrossRef
    • Sirtuin 1 is not required for contraction-stimulated glucose uptake in mouse skeletal muscle
      Ji H. Kang, Ji E. Park, Jason Dagoon, Stewart W. C. Masson, Troy L. Merry, Shannon N. Bremner, Jessica R. Dent, Simon Schenk
      Journal of Applied Physiology.2021; 130(6): 1893.     CrossRef
    • TRPV1 Activation by Capsaicin Mediates Glucose Oxidation and ATP Production Independent of Insulin Signalling in Mouse Skeletal Muscle Cells
      Parisa Vahidi Ferdowsi, Kiran D. K. Ahuja, Jeffrey M. Beckett, Stephen Myers
      Cells.2021; 10(6): 1560.     CrossRef
    • Effects of exercise on cellular and tissue aging
      Priscila Viana Carapeto, Cristina Aguayo-Mazzucato
      Aging.2021; 13(10): 14522.     CrossRef
    • Biglycan reduces body weight by regulating food intake in mice and improves glucose metabolism through AMPK/AKT dual pathways in skeletal muscle
      InHyeok Chung, Shin Ae Kim, Seolsong Kim, Jung Ok Lee, Clara Yongjoo Park, Juhee Lee, Jun Kang, Jin Young Lee, Ilhyeok Seo, Hye Jeong Lee, Jeong Ah Han, Min Ju Kang, Eunice Lim, Su Jin Kim, Sang Woo Wu, Joo Yeon Oh, Ji Hyung Chung, Eun‐Kyoung Kim, Hyeon S
      The FASEB Journal.2021;[Epub]     CrossRef
    • A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan
      Ibrahim Mohammed, Morley D. Hollenberg, Hong Ding, Chris R. Triggle
      Frontiers in Endocrinology.2021;[Epub]     CrossRef
    • The acute vs. chronic effect of exercise on insulin sensitivity: nothing lasts forever
      Fred J. DiMenna, Avigdor D. Arad
      Cardiovascular Endocrinology & Metabolism.2021; 10(3): 149.     CrossRef
    • Comparative analyses of liver transcriptomes reveal the effect of exercise on growth-, glucose metabolism-, and oxygen transport-related genes and signaling pathways in grass carp (Ctenopharyngodon idella)
      Lang Zhang, Xiaohui Li, Yali Yu, Lin Zhang, Lixue Dong, Jinhua Gan, Tao Mao, Ting Liu, Jie Peng, Li He
      Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology.2021; 262: 111081.     CrossRef
    • Effects of moderate exercise on hepatic amino acid and fatty acid composition, liver transcriptome, and intestinal microbiota in channel catfish (Ictalurus punctatus)
      Lang Zhang, Yali Yu, Lixue Dong, Jinhua Gan, Tao Mao, Ting Liu, Xiaohui Li, Li He
      Comparative Biochemistry and Physiology Part D: Genomics and Proteomics.2021; 40: 100921.     CrossRef
    • Mangosteen xanthone γ-mangostin exerts lowering blood glucose effect with potentiating insulin sensitivity through the mediation of AMPK/PPARγ
      Sih-Pei Chen, Shian-Ren Lin, Ting-Hsu Chen, Hui-Suan Ng, Hip-Seng Yim, Max K. Leong, Ching-Feng Weng
      Biomedicine & Pharmacotherapy.2021; 144: 112333.     CrossRef
    • The effects of naringenin and naringin on the glucose uptake and AMPK phosphorylation in high glucose treated HepG2 cells
      Lakshi A. Dayarathne, Sachithra S. Ranaweera, Premkumar Natraj, Priyanka Rajan, Young Jae Lee, Chang-Hoon Han
      Journal of Veterinary Science.2021;[Epub]     CrossRef
    • Inhibition of Digestive Enzyme and Stimulation of Human Liver Cells (HepG2) Glucose Uptake by Date Seeds Extract
      Hira Shakoor, Fatima Abdelfattah, Khaula Albadi, Mentalla Adib, Jaleel Kizhakkayil, Carine Platat
      Evidence-Based Complementary and Alternative Medicine.2020; 2020: 1.     CrossRef
    • Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin
      Saman Bahrambeigi, Vahid Shafiei-Irannejad
      Biochemical Pharmacology.2020; 174: 113787.     CrossRef
    • Excess Accumulation of Lipid Impairs Insulin Sensitivity in Skeletal Muscle
      Sung Sup Park, Young-Kyo Seo
      International Journal of Molecular Sciences.2020; 21(6): 1949.     CrossRef
    • Regulation of podocytes function by AMP-activated protein kinase
      Dorota Rogacka, Irena Audzeyenka, Agnieszka Piwkowska
      Archives of Biochemistry and Biophysics.2020; 692: 108541.     CrossRef
    • AMPK'nin Biyokimyası: Etki Mekanizmaları ve Diyabetin Tedavisindeki Önemi
      Cemalettin KİSMİROĞLU, Serdar CENGİZ, Mustafa YAMAN
      European Journal of Science and Technology.2020; : 162.     CrossRef
    • Potent Inhibitory Effect of BJ-3105, a 6-Alkoxypyridin-3-ol Derivative, on Murine Colitis Is Mediated by Activating AMPK and Inhibiting NOX
      Pallavi Gurung, Sadan Dahal, Prakash Chaudhary, Diwakar Guragain, Ujjwala Karmacharya, Jung-Ae Kim, Byeong-Seon Jeong
      International Journal of Molecular Sciences.2020; 21(9): 3145.     CrossRef
    • Exchange protein directly activated by cAMP (Epac) 1 plays an essential role in stress-induced exercise capacity by regulating PGC-1α and fatty acid metabolism in skeletal muscle
      Wai-Kin So, Hyoung Kyu Kim, Yingxian Chen, Seung Hun Jeong, Patrick Ka Kit Yeung, Billy C. K. Chow, Jin Han, Sookja K. Chung
      Pflügers Archiv - European Journal of Physiology.2020; 472(2): 195.     CrossRef
    • Metformin ameliorates animal models of dermatitis
      Soo Young Choi, Chanmi Lee, Min-Jeong Heo, Yeong Min Choi, In-sook An, Seunghee Bae, Sungkwan An, Jin Hyuk Jung
      Inflammopharmacology.2020; 28(5): 1293.     CrossRef
    • Design, synthesis and biological evaluation of mogrol derivatives as a novel class of AMPKα2β1γ1 activators
      Junwei Wang, Junhua Liu, Zhifu Xie, Jia Li, Jingya Li, Lihong Hu
      Bioorganic & Medicinal Chemistry Letters.2020; 30(2): 126790.     CrossRef
    • The myokine meteorin‐like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKα2
      Jung Ok Lee, Won Seok Byun, Min Ju Kang, Jeong Ah Han, Jiyoung Moon, Min‐Jeong Shin, Ho Jun Lee, Ji Hyung Chung, Jin‐Seok Lee, Chang‐Gue Son, Kwon‐Ho Song, Tae Woo Kim, Eun‐Soo Lee, Hong Min Kim, Choon Hee Chung, Kevin R. W. Ngoei, Naomi X. Y. Ling, Jonat
      The FEBS Journal.2020; 287(10): 2087.     CrossRef
    • Impact of Isoorientin on Metabolic Activity and Lipid Accumulation in Differentiated Adipocytes
      Khanyisani Ziqubu, Christo J. F. Muller, Phiwayinkosi V. Dludla, Sinenhlanhla X. H. Mthembu, Nnini Obonye, Johan Louw, Abidemi P. Kappo, Sonia Silvestri, Patrick Orlando, Luca Tiano, Sithandiwe E. Mazibuko-Mbeje
      Molecules.2020; 25(8): 1773.     CrossRef
    • Mitochondrial dysfunction regulates the JAK–STAT pathway via LKB1-mediated AMPK activation ER-stress-independent manner
      Dong-Yeon Kim, Su-Geun Lim, Kyoungho Suk, Won-Ha Lee
      Biochemistry and Cell Biology.2020; 98(2): 137.     CrossRef
    • cis-Banglene, a bangle (Zingiber purpureum)-derived bioactive compound, promotes mitochondrial biogenesis and glucose uptake by activating the IL-6/AMPK signaling pathway in C2C12 skeletal muscle cells
      Toshio Norikura, Shiori Kajiya, Mami Sugawara, Miwa Kubo, Yoshiyasu Fukuyama, Shin Sato
      Journal of Functional Foods.2020; 64: 103632.     CrossRef
    • Delayed Exercise Training Improves Obesity-Induced Chronic Kidney Disease by Activating AMPK Pathway in High-Fat Diet-Fed Mice
      Florian Juszczak, Maud Vlassembrouck, Olivia Botton, Thomas Zwakhals, Morgane Decarnoncle, Alexandra Tassin, Nathalie Caron, Anne-Emilie Declèves
      International Journal of Molecular Sciences.2020; 22(1): 350.     CrossRef
    • The Regulation of Fat Metabolism during Aerobic Exercise
      Antonella Muscella, Erika Stefàno, Paola Lunetti, Loredana Capobianco, Santo Marsigliante
      Biomolecules.2020; 10(12): 1699.     CrossRef
    • Chronic neuromuscular electrical stimulation improves muscle mass and insulin sensitivity in a mouse model
      Adiel Lotri-Koffi, Marion Pauly, Emeline Lemarié, Diane Godin-Ribuot, Renaud Tamisier, Jean-Louis Pépin, Isabelle Vivodtzev
      Scientific Reports.2019;[Epub]     CrossRef
    • Effect of Aerobic and Resistance Exercise Intervention on Cardiovascular Disease Risk in Women With Early-Stage Breast Cancer
      Kyuwan Lee, Debu Tripathy, Wendy Demark-Wahnefried, Kerry S. Courneya, Nathalie Sami, Leslie Bernstein, Darcy Spicer, Thomas A. Buchanan, Joanne E. Mortimer, Christina M. Dieli-Conwright
      JAMA Oncology.2019; 5(5): 710.     CrossRef
    • Semen Cuscutae Administration Improves Hepatic Lipid Metabolism and Adiposity in High Fat Diet-Induced Obese Mice
      Jiyoung Moon, Min Jin Ha, Min-Jeong Shin, Oh Yoen Kim, Eun Hye Yoo, Juhyun Song, Ji Hyung Chung
      Nutrients.2019; 11(12): 3035.     CrossRef
    • Anthraquinone-type inhibitor of α-glucosidase enhances glucose uptake by activating an insulin-like signaling pathway in C2C12 myotubes
      Md Badrul Alam, Vivek K. Bajpai, Jeong-Sic Ra, Ji-Young Lim, Hongyan An, Shruti Shukla, Khong Trong Quan, Imran Khan, Yun Suk Huh, Young-Kyu Han, MinKyun Na, Sang-Han Lee
      Food and Chemical Toxicology.2019; 129: 337.     CrossRef
    • AMPKα2 Deficiency Does Not Affect the Exercise-Induced Improvements in Glucose Tolerance and Metabolic Disorders in Mice Fed a High-Fat Diet
      Zhong-Guang SUN, Ge TIAN, Xiao-Ci ZHENG, Wen-Ying LIU, Xue-Ting LUO, Jing XIAO, Hui SONG, Xin XU
      Journal of Nutritional Science and Vitaminology.2019; 65(6): 491.     CrossRef
    • Electrical pulse stimulation induces differential responses in insulin action in myotubes from severely obese individuals
      Sanghee Park, Kristen D. Turner, Donghai Zheng, Jeffrey J. Brault, Kai Zou, Alec B. Chaves, Thomas S. Nielsen, Charles J. Tanner, Jonas T. Treebak, Joseph A. Houmard
      The Journal of Physiology.2019; 597(2): 449.     CrossRef
    • Mechanisms Involved in Glycemic Control Promoted by Exercise in Diabetics
      Eric Francelino Andrade, Víviam de Oliveira Silva, Débora Ribeiro Orlando, Luciano José Pereira
      Current Diabetes Reviews.2019; 15(2): 105.     CrossRef
    • Eicosapentaenoic Acid (EPA) Modulates Glucose Metabolism by Targeting AMP-Activated Protein Kinase (AMPK) Pathway
      Nami Kim, Mi Sun Kang, Miso Nam, Shin Ae Kim, Geum-Sook Hwang, Hyeon Soo Kim
      International Journal of Molecular Sciences.2019; 20(19): 4751.     CrossRef
    • Aerobic Exercise Training Decreases Hepatic Asprosin in Diabetic Rats
      Jeong Rim Ko, Dae Yun Seo, Tae Nyun Kim, Se Hwan Park, Hyo-Bum Kwak, Kyung Soo Ko, Byoung Doo Rhee, Jin Han
      Journal of Clinical Medicine.2019; 8(5): 666.     CrossRef
    • Metformin; an old antidiabetic drug with new potentials in bone disorders
      Saman Bahrambeigi, Bahman Yousefi, Mahdi Rahimi, Vahid Shafiei-Irannejad
      Biomedicine & Pharmacotherapy.2019; 109: 1593.     CrossRef
    • A comparative analysis of various flavonoids in the regulation of obesity and diabetes: An in vitro and in vivo study
      Ritu Varshney, Rutusmita Mishra, Neeladrisingha Das, Debabrata Sircar, Partha Roy
      Journal of Functional Foods.2019; 59: 194.     CrossRef
    • Akt activation: A potential strategy to ameliorate insulin resistance
      Zhengyi Zhang, Huadong Liu, Jiankang Liu
      Diabetes Research and Clinical Practice.2019; 156: 107092.     CrossRef
    • Chitosan encapsulated nanocurcumin induces GLUT-4 translocation and exhibits enhanced anti-hyperglycemic function
      Pratibha Chauhan, Akhilesh Kumar Tamrakar, Sunil Mahajan, G.B.K.S. Prasad
      Life Sciences.2018; 213: 226.     CrossRef
    • Occludin regulates glucose uptake and ATP production in pericytes by influencing AMP-activated protein kinase activity
      Victor Castro, Marta Skowronska, Jorge Lombardi, Jane He, Neil Seth, Martina Velichkovska, Michal Toborek
      Journal of Cerebral Blood Flow & Metabolism.2018; 38(2): 317.     CrossRef
    • Interactions between dietary carbohydrate and metformin: Implications on energy sensing, insulin signaling pathway, glycolipid metabolism and glucose tolerance in blunt snout bream Megalobrama amblycephala
      Chao Xu, Wen-Bin Liu, Ding-Dong Zhang, Xiu-Fei Cao, Hua-Juan Shi, Xiang-Fei Li
      Aquaculture.2018; 483: 183.     CrossRef
    • Gossypol from Cottonseeds Ameliorates Glucose Uptake by Mimicking Insulin Signaling and Improves Glucose Homeostasis in Mice with Streptozotocin-Induced Diabetes
      Md Badrul Alam, Hongyan An, Jeong-Sic Ra, Ji-young Lim, Seung-Hyun Lee, Chi-Yeol Yoo, Sang-Han Lee
      Oxidative Medicine and Cellular Longevity.2018; 2018: 1.     CrossRef
    • PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients
      Pär Steneberg, Emma Lindahl, Ulf Dahl, Emmelie Lidh, Jurate Straseviciene, Fredrik Backlund, Elisabet Kjellkvist, Eva Berggren, Ingela Lundberg, Ingela Bergqvist, Madelene Ericsson, Björn Eriksson, Kajsa Linde, Jacob Westman, Thomas Edlund, Helena Edlund
      JCI Insight.2018;[Epub]     CrossRef
    • Aerobic exercise training decreases cereblon and increases AMPK signaling in the skeletal muscle of STZ-induced diabetic rats
      Jeong Rim Ko, Dae Yun Seo, Se Hwan Park, Hyo Bum Kwak, Min Kim, Kyung Soo Ko, Byoung Doo Rhee, Jin Han
      Biochemical and Biophysical Research Communications.2018; 501(2): 448.     CrossRef
    • AMPK in skeletal muscle function and metabolism
      Rasmus Kjøbsted, Janne R. Hingst, Joachim Fentz, Marc Foretz, Maria‐Nieves Sanz, Christian Pehmøller, Michael Shum, André Marette, Remi Mounier, Jonas T. Treebak, Jørgen F. P. Wojtaszewski, Benoit Viollet, Louise Lantier
      The FASEB Journal.2018; 32(4): 1741.     CrossRef
    • Exercise improves glucose uptake in murine myotubes through the AMPKα2-mediated induction of Sestrins
      Tianyi Wang, Yanmei Niu, Sujuan Liu, Hairui Yuan, Xiaolei Liu, Li Fu
      Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2018; 1864(10): 3368.     CrossRef
    • Resveratrol ameliorates autophagic flux to promote functional recovery in rats after spinal cord injury
      Peng Wang, Lizhu Jiang, Nian Zhou, Hao Zhou, Huzhe Liu, Wenrui Zhao, Hanxiang Zhang, Xiang Zhang, Zhenming Hu
      Oncotarget.2018; 9(9): 8427.     CrossRef
    • Cocoa Flavanol Supplementation and Exercise: A Systematic Review
      Lieselot Decroix, Danusa Dias Soares, Romain Meeusen, Elsa Heyman, Cajsa Tonoli
      Sports Medicine.2018; 48(4): 867.     CrossRef
    • Exercise and Mitochondrial Remodeling in Skeletal Muscle in Type 2 Diabetes
      Hojun Lee, Wook Song
      Journal of Obesity & Metabolic Syndrome.2018; 27(3): 150.     CrossRef
    • Vernonia cinerea water extract improves insulin resistance in high-fat diet–induced obese mice
      Jarinyaporn Naowaboot, Supaporn Wannasiri, Patchareewan Pannangpetch
      Nutrition Research.2018; 56: 51.     CrossRef
    • Cell-Specific “Competition for Calories” Drives Asymmetric Nutrient-Energy Partitioning, Obesity, and Metabolic Diseases in Human and Non-human Animals
      Edward Archer, Gregory Pavela, Samantha McDonald, Carl J. Lavie, James O. Hill
      Frontiers in Physiology.2018;[Epub]     CrossRef
    • Hypothalamic AMPK as a Mediator of Hormonal Regulation of Energy Balance
      Baile Wang, Kenneth Cheng
      International Journal of Molecular Sciences.2018; 19(11): 3552.     CrossRef
    • Discovery of MK-8722: A Systemic, Direct Pan-Activator of AMP-Activated Protein Kinase
      Danqing Feng, Tesfaye Biftu, F. Anthony Romero, Ahmet Kekec, James Dropinski, Andrew Kassick, Shiyao Xu, Marc M. Kurtz, Anantha Gollapudi, Qing Shao, Xiaodong Yang, Ku Lu, Gaochao Zhou, Daniel Kemp, Robert W. Myers, Hong-Ping Guan, Maria E. Trujillo, Cai
      ACS Medicinal Chemistry Letters.2018; 9(1): 39.     CrossRef
    • 2-Bromo-4′-methoxychalcone and 2-Iodo-4′-methoxychalcone Prevent Progression of Hyperglycemia and Obesity via 5′-Adenosine-Monophosphate-Activated Protein Kinase in Diet-Induced Obese Mice
      Chi-Ting Hsieh, Fang-Rong Chang, Yi-Hong Tsai, Yang-Chang Wu, Tusty-Jiuan Hsieh
      International Journal of Molecular Sciences.2018; 19(9): 2763.     CrossRef
    • Dynamic transcriptomic analysis in hircine longissimus dorsi muscle from fetal to neonatal development stages
      Siyuan Zhan, Wei Zhao, Tianzeng Song, Yao Dong, Jiazhong Guo, Jiaxue Cao, Tao Zhong, Linjie Wang, Li Li, Hongping Zhang
      Functional & Integrative Genomics.2018; 18(1): 43.     CrossRef
    • Oyster mushroom functions as an anti-hyperglycaemic through phosphorylation of AMPK and increased expression of GLUT4 in type 2 diabetic model rats
      Mohammad Asrafuzzaman, Mohammad M. Rahman, Manoj Mandal, Mohammad Marjuque, Amrita Bhowmik, Begum Rokeya, Zahid Hassan, Mohammad Omar Faruque
      Journal of Taibah University Medical Sciences.2018; 13(5): 465.     CrossRef
    • AMP-activated protein kinase α1 in Megalobrama amblycephala: Molecular characterization and the transcriptional modulation by nutrient restriction and glucose and insulin loadings
      Chao Xu, Xiang-Fei Li, Hua-Juan Shi, Jie Liu, Li Zhang, Wen-Bin Liu
      General and Comparative Endocrinology.2018; 267: 66.     CrossRef
    • Comprehensive Relevance of AMPK in Adaptive Responses of Physical Exercise, Skeletal Muscle and Neuromuscular Disorders
      Jun-Ho Lee
      Journal of The Korean Society of Physical Medicine.2018; 13(3): 141.     CrossRef
    • Interactive Roles for AMPK and Glycogen from Cellular Energy Sensing to Exercise Metabolism
      Natalie Janzen, Jamie Whitfield, Nolan Hoffman
      International Journal of Molecular Sciences.2018; 19(11): 3344.     CrossRef
    • Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse
      Tue L. Nielsen, Tomàs Pinós, Astrid Brull, John Vissing, Thomas O. Krag
      Molecular Genetics and Metabolism.2018; 123(1): 21.     CrossRef
    • Pharmacological Activities of Mogrosides
      Can Liu, Longhai Dai, Yueping Liu, Dequan Dou, Yuanxia Sun, Lanqing Ma
      Future Medicinal Chemistry.2018; 10(8): 845.     CrossRef
    • Structural Determinants for Small-Molecule Activation of Skeletal Muscle AMPK α2β2γ1 by the Glucose Importagog SC4
      Kevin R.W. Ngoei, Christopher G. Langendorf, Naomi X.Y. Ling, Ashfaqul Hoque, Swapna Varghese, Michelle A. Camerino, Scott R. Walker, Ylva E. Bozikis, Toby A. Dite, Ashley J. Ovens, William J. Smiles, Roxane Jacobs, He Huang, Michael W. Parker, John W. Sc
      Cell Chemical Biology.2018; 25(6): 728.     CrossRef
    • Fiber type-specific analysis of AMPK isoforms in human skeletal muscle: advancement in methods via capillary nanoimmunoassay
      Irene S. Tobias, Kara K. Lazauskas, Jose A. Arevalo, James R. Bagley, Lee E. Brown, Andrew J. Galpin
      Journal of Applied Physiology.2018; 124(4): 840.     CrossRef
    • Insulin Mimetic Activity of 3,4-Seco and Hexanordammarane Triterpenoids Isolated from Gynostemma longipes
      Ha Thanh Tung Pham, Thi Kim Quy Ha, Hyo Moon Cho, Ba Wool Lee, Jin Pyo An, Van On Tran, Won Keun Oh
      Journal of Natural Products.2018; 81(11): 2470.     CrossRef
    • Subcutaneous adipose tissue accumulation protects systemic glucose tolerance and muscle metabolism
      A.D. Booth, A.M. Magnuson, J. Fouts, Y. Wei, D. Wang, M.J. Pagliassotti, M.T. Foster
      Adipocyte.2018; 7(4): 261.     CrossRef
    • Host Adaptive Immune Status Regulates Expression of the Schistosome AMP-Activated Protein Kinase
      Kasandra S. Hunter, Stephen J. Davies
      Frontiers in Immunology.2018;[Epub]     CrossRef
    • Neurogenic obesity and systemic inflammation following spinal cord injury: A review
      Gary J. Farkas, David R. Gater
      The Journal of Spinal Cord Medicine.2018; 41(4): 378.     CrossRef
    • In Defense of Sugar: A Critique of Diet-Centrism
      Edward Archer
      Progress in Cardiovascular Diseases.2018; 61(1): 10.     CrossRef
    • Anti-inflammatory effects induced by pharmaceutical substances on inflammatory active brain astrocytes—promising treatment of neuroinflammation
      Elisabeth Hansson, Ulrika Björklund, Eva Skiöldebrand, Lars Rönnbäck
      Journal of Neuroinflammation.2018;[Epub]     CrossRef
    • Cucurbitane Triterpenoids from the Fruits of Momordica Charantia Improve Insulin Sensitivity and Glucose Homeostasis in Streptozotocin‐Induced Diabetic Mice
      Joo‐Hui Han, Nguyen Quoc Tuan, Min‐Ho Park, Khong Trong Quan, Joonseok Oh, Kyung‐Sun Heo, MinKyun Na, Chang‐Seon Myung
      Molecular Nutrition & Food Research.2018;[Epub]     CrossRef
    • Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy
      Robert W. Myers, Hong-Ping Guan, Juliann Ehrhart, Aleksandr Petrov, Srinivasa Prahalada, Effie Tozzo, Xiaodong Yang, Marc M. Kurtz, Maria Trujillo, Dinko Gonzalez Trotter, Danqing Feng, Shiyao Xu, George Eiermann, Marie A. Holahan, Daniel Rubins, Stacey C
      Science.2017; 357(6350): 507.     CrossRef
    • Pioglitazone-induced bone loss in diabetic rats and its amelioration by berberine: A portrait of molecular crosstalk
      Mohammad Adil, Mohd Nizam Mansoori, Divya Singh, Amit Dattatraya Kandhare, Manju Sharma
      Biomedicine & Pharmacotherapy.2017; 94: 1010.     CrossRef
    • Rb2 inhibits α-glucosidase and regulates glucose metabolism by activating AMPK pathways in HepG2 cells
      Hui Teng, Lei Chen, Ting Fang, Benyao Yuan, Qiyang Lin
      Journal of Functional Foods.2017; 28: 306.     CrossRef
    • The Emerging Role of Thioredoxin-Interacting Protein in Myocardial Ischemia/Reperfusion Injury
      Bing F. Wang, Jun Yoshioka
      Journal of Cardiovascular Pharmacology and Therapeutics.2017; 22(3): 219.     CrossRef
    • Efectos del ejercicio físico en los factores de riesgo cardiovascular que constituyen el síndrome metabólico: una alternativa para reducir su tendencia
      Adrián Hernández Alonso
      Revista Colombiana de Médicina Física y Rehabilitación.2017; 27(2): 140.     CrossRef
    • Piperine regulates UCP1 through the AMPK pathway by generating intracellular lactate production in muscle cells
      Nami Kim, Miso Nam, Mi Sun Kang, Jung Ok Lee, Yong Woo Lee, Geum-Sook Hwang, Hyeon Soo Kim
      Scientific Reports.2017;[Epub]     CrossRef
    • Vitamin D supplementation inhibits oxidative stress and upregulate SIRT1/AMPK/GLUT4 cascade in high glucose-treated 3T3L1 adipocytes and in adipose tissue of high fat diet-fed diabetic mice
      Prasenjit Manna, Arunkumar E. Achari, Sushil K. Jain
      Archives of Biochemistry and Biophysics.2017; 615: 22.     CrossRef
    • Care of the Athlete With Type 1 Diabetes Mellitus: A Clinical Review
      William B. Horton, Jose S. Subauste
      International Journal of Endocrinology and Metabolism.2016;[Epub]     CrossRef
    • Cheonggukjang, a soybean paste fermented with B. licheniformis-67 prevents weight gain and improves glycemic control in high fat diet induced obese mice
      Joo-Hee Choi, P.B.Tirupathi Pichiah, Min-Jung Kim, Youn-Soo Cha
      Journal of Clinical Biochemistry and Nutrition.2016; 59(1): 31.     CrossRef
    • Rg3 Improves Mitochondrial Function and the Expression of Key Genes Involved in Mitochondrial Biogenesis in C2C12 Myotubes
      Min Joo Kim, Young Do Koo, Min Kim, Soo Lim, Young Joo Park, Sung Soo Chung, Hak C. Jang, Kyong Soo Park
      Diabetes & Metabolism Journal.2016; 40(5): 406.     CrossRef
    • Phytochemicals in regulating fatty acid β-oxidation: Potential underlying mechanisms and their involvement in obesity and weight loss
      H.P. Vasantha Rupasinghe, Satvir Sekhon-Loodu, Theodora Mantso, Mihalis I. Panayiotidis
      Pharmacology & Therapeutics.2016; 165: 153.     CrossRef
    • Insulin Signaling and Glucose Uptake in the Soleus Muscle of 30-Month-Old Rats After Calorie Restriction With or Without Acute Exercise
      Haiyan Wang, Naveen Sharma, Edward B. Arias, Gregory D. Cartee
      The Journals of Gerontology Series A: Biological Sciences and Medical Sciences.2016; 71(3): 323.     CrossRef
    • Acute resistance exercise-induced IGF1 expression and subsequent GLUT4 translocation
      Kohei Kido, Satoru Ato, Takumi Yokokawa, Yuhei Makanae, Koji Sato, Satoshi Fujita
      Physiological Reports.2016; 4(16): e12907.     CrossRef
    • Regulation and function of AMPK in physiology and diseases
      Sang-Min Jeon
      Experimental & Molecular Medicine.2016; 48(7): e245.     CrossRef
    • Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A)
      Junjeong Choi, Ji-Hyun Lee, Ilkyoo Koh, Jin-Kyoung Shim, Junseong Park, Jeong Yong Jeon, Mijin Yun, Se Hoon Kim, Jong In Yook, Eui Hyun Kim, Jong Hee Chang, Sun Ho Kim, Yong Min Huh, Su Jae Lee, Michael Pollak, Pilnam Kim, Seok-Gu Kang, Jae-Ho Cheong
      Oncotarget.2016; 7(40): 65643.     CrossRef
    • [6]‐Gingerol Affects Glucose Metabolism by Dual Regulation via the AMPKα2‐Mediated AS160–Rab5 Pathway and AMPK‐Mediated Insulin Sensitizing Effects
      Jung Ok Lee, Nami Kim, Hye Jeong Lee, Ji Wook Moon, Soo Kyung Lee, Su Jin Kim, Joong Kwan Kim, Sun Hwa Park, Hyeon Soo Kim
      Journal of Cellular Biochemistry.2015; 116(7): 1401.     CrossRef
    • A glance at … exercise and glucose uptake
      Michael J. Glade, Kyl Smith
      Nutrition.2015; 31(6): 893.     CrossRef
    • Exercising insulin sensitivity: AMPK turns on autophagy!
      Yossi Dagon, Christos Mantzoros, Young-Bum Kim
      Metabolism.2015; 64(6): 655.     CrossRef
    • Leucine supplementation does not affect protein turnover and impairs the beneficial effects of endurance training on glucose homeostasis in healthy mice
      José M. Costa Júnior, Morgana R. Rosa, André O. Protzek, Flávia M. de Paula, Sandra M. Ferreira, Luiz F. Rezende, Emerielle C. Vanzela, Cláudio C. Zoppi, Leonardo R. Silveira, Isis C. Kettelhut, Antonio C. Boschero, Camila A. M. de Oliveira, Everardo M. C
      Amino Acids.2015; 47(4): 745.     CrossRef
    • Endoplasmic reticulum chaperone GRP78 is involved in autophagy activation induced by ischemic preconditioning in neural cells
      Xiang-Yang Zhang, Tong-Tong Zhang, Dan-Dan Song, Jun- Hao Zhou, Rong Han, Zheng-Hong Qin, Rui Sheng
      Molecular Brain.2015;[Epub]     CrossRef
    • Identification of adenine modulating AMPK activation in NIH/3T3 cells by proteomic approach
      Guang-Huar Young, Jiun-Tsai Lin, Yi-Fang Cheng, Chun-Fang Huang, Cheng-Yu Chao, Jing-Yi Nong, Po-Ku Chen, Han-Min Chen
      Journal of Proteomics.2015; 120: 204.     CrossRef
    • Mechanisms for independent and combined effects of calorie restriction and acute exercise on insulin-stimulated glucose uptake by skeletal muscle of old rats
      Naveen Sharma, Haiyan Wang, Edward B. Arias, Carlos M. Castorena, Gregory D. Cartee
      American Journal of Physiology-Endocrinology and Metabolism.2015; 308(7): E603.     CrossRef
    • Human muscle fibre type‐specific regulation of AMPK and downstream targets by exercise
      Dorte E. Kristensen, Peter H. Albers, Clara Prats, Otto Baba, Jesper B. Birk, Jørgen F. P. Wojtaszewski
      The Journal of Physiology.2015; 593(8): 2053.     CrossRef
    • Phenolic compounds ameliorate the glucose uptake in HepG2 cells' insulin resistance via activating AMPK
      Qun Huang, Lei Chen, Hui Teng, Hongbo Song, Xiaoqi Wu, Meiyu Xu
      Journal of Functional Foods.2015; 19: 487.     CrossRef
    • Celastrol Protects against Antimycin A-Induced Insulin Resistance in Human Skeletal Muscle Cells
      Mohamad Abu Bakar, Kian-Kai Cheng, Mohamad Sarmidi, Harisun Yaakob, Hasniza Huri
      Molecules.2015; 20(5): 8242.     CrossRef
    • Glucose uptake in human brown adipose tissue is impaired upon fasting-induced insulin resistance
      Mark J. W. Hanssen, Roel Wierts, Joris Hoeks, Anne Gemmink, Boudewijn Brans, Felix M. Mottaghy, Patrick Schrauwen, Wouter D. van Marken Lichtenbelt
      Diabetologia.2015; 58(3): 586.     CrossRef
    • Skeletal muscle ACC2 S212 phosphorylation is not required for the control of fatty acid oxidation during exercise
      Hayley M. O'Neill, James S. Lally, Sandra Galic, Thomas Pulinilkunnil, Rebecca J. Ford, Jason R. B. Dyck, Bryce J. van Denderen, Bruce E. Kemp, Gregory R. Steinberg
      Physiological Reports.2015; 3(7): e12444.     CrossRef
    • Adenosine Monophosphate–Activated Kinase and Its Key Role in Catabolism: Structure, Regulation, Biological Activity, and Pharmacological Activation
      Sukriti Krishan, Des R. Richardson, Sumit Sahni
      Molecular Pharmacology.2015; 87(3): 363.     CrossRef
    • Role of AMPK and PPARγ1 in exercise-induced lipoprotein lipase in skeletal muscle
      Takashi Sasaki, Rieko Nakata, Hiroyasu Inoue, Makoto Shimizu, Jun Inoue, Ryuichiro Sato
      American Journal of Physiology-Endocrinology and Metabolism.2014; 306(9): E1085.     CrossRef
    • A novel heterozygous mutation in the glucokinase gene conferring exercise-induced symptomatic hyperglycaemia responsive to sulfonylurea
      M.S.E. Ebrahim, M.L. Lawson, M.T. Geraghty
      Diabetes & Metabolism.2014; 40(4): 310.     CrossRef
    • Anti-obesity and anti-insulin resistance effects of tomato vinegar beverage in diet-induced obese mice
      Kwon-Il Seo, Jin Lee, Ra-Yeong Choi, Hae-In Lee, Ju-Hye Lee, Yong-Ki Jeong, Myung-Joo Kim, Mi-Kyung Lee
      Food & Function.2014; 5(7): 1579.     CrossRef
    • The AMPK-SIRT signaling network regulates glucose tolerance under calorie restriction conditions
      M.F.P. Silvestre, B. Viollet, P.W. Caton, J. Leclerc, I. Sakakibara, M. Foretz, M.C. Holness, M.C. Sugden
      Life Sciences.2014; 100(1): 55.     CrossRef
    • Calanquinone A induces anti-glioblastoma activity through glutathione-involved DNA damage and AMPK activation
      Fan-Lun Liu, Jui-Ling Hsu, Yean-Jang Lee, Yu-Shun Dong, Fan-Lu Kung, Ching-Shih Chen, Jih-Hwa Guh
      European Journal of Pharmacology.2014; 730: 90.     CrossRef
    • Fighting obesity: When muscle meets fat
      Xin Yang, Pengpeng Bi, Shihuan Kuang
      Adipocyte.2014; 3(4): 280.     CrossRef
    • Quercetin attenuates renal ischemia/reperfusion injury via an activation of AMP-activated protein kinase-regulated autophagy pathway
      Bo-Lin Chen, Li-Ting Wang, Kuo-How Huang, Ching-Chia Wang, Chih-Kang Chiang, Shing-Hwa Liu
      The Journal of Nutritional Biochemistry.2014; 25(11): 1226.     CrossRef
    • AMPK controls exercise endurance, mitochondrial oxidative capacity, and skeletal muscle integrity
      Louise Lantier, Joachim Fentz, Rémi Mounier, Jocelyne Leclerc, Jonas T. Treebak, Christian Pehmøller, Nieves Sanz, Iori Sakakibara, Emmanuelle Saint‐Amand, Stéphanie Rimbaud, Pascal Maire, André Marette, Renée Ventura‐Clapier, Arnaud Ferry, Jørgen F. P. W
      The FASEB Journal.2014; 28(7): 3211.     CrossRef
    • Activation of AMPKα2 Is Not Crucial for Mitochondrial Uncoupling-Induced Metabolic Effects but Required to Maintain Skeletal Muscle Integrity
      Mario Ost, Franziska Werner, Janine Dokas, Susanne Klaus, Anja Voigt, Juergen Eckel
      PLoS ONE.2014; 9(4): e94689.     CrossRef
    • Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo
      Min-Jung Park, Dong-Il Kim, Seul-Ki Lim, Joo-Hee Choi, Jong-Choon Kim, Kyung-Chul Yoon, Jee-Bum Lee, Jae-Hyuk Lee, Ho-Jae Han, In-Pyo Choi, Hyoung-Chin Kim, Soo-Hyun Park
      Journal of Hepatology.2014; 61(5): 1151.     CrossRef
    • Liraglutide enhances glucose transporter 4 translocation via regulation of AMP-activated protein kinase signaling pathways in mouse skeletal muscle cells
      Zhu Li, Chang-Lin Ni, Zhi Yao, Li-Ming Chen, Wen-Yan Niu
      Metabolism.2014; 63(8): 1022.     CrossRef
    • Effects of metformin on weight loss
      Steven K. Malin, Sangeeta R. Kashyap
      Current Opinion in Endocrinology, Diabetes & Obesity.2014; 21(5): 323.     CrossRef
    • Changes of Blood Glucose and Lactate Concentration in Body Wearing Firefighting Protective Equipments
      Chang-Hoon Bang
      Journal of Korean Society of Hazard Mitigation.2014; 14(1): 263.     CrossRef
    • Exercise, Energy Intake, Glucose Homeostasis, and the Brain
      Henriette van Praag, Monika Fleshner, Michael W. Schwartz, Mark P. Mattson
      The Journal of Neuroscience.2014; 34(46): 15139.     CrossRef
    • The Effects of Exercise Training on Obesity-Induced Dysregulated Expression of Adipokines in White Adipose Tissue
      Takuya Sakurai, Junetsu Ogasawara, Takako Kizaki, Shogo Sato, Yoshinaga Ishibashi, Motoko Takahashi, Osamu Kobayashi, Shuji Oh-ishi, Junichi Nagasawa, Kazuto Takahashi, Hitoshi Ishida, Tetsuya Izawa, Hideki Ohno
      International Journal of Endocrinology.2013; 2013: 1.     CrossRef
    • Flavonoids from Tetrastigma obtectum enhancing glucose consumption in insulin-resistance HepG2 cells via activating AMPK
      Mei-Na Jin, Guo-Ru Shi, Sheng-An Tang, Nan-Qin, Wei Qiao, Hong-Quan Duan
      Fitoterapia.2013; 90: 240.     CrossRef
    • AMPK, insulin resistance, and the metabolic syndrome
      Neil B. Ruderman, David Carling, Marc Prentki, José M. Cacicedo
      Journal of Clinical Investigation.2013; 123(7): 2764.     CrossRef
    • Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming
      Veronica Martinez Marignac, Sarah Smith, Nader Toban, Miguel Bazile, Raquel Aloyz
      Oncotarget.2013; 4(12): 2550.     CrossRef
    • Improvement of vascular insulin sensitivity by downregulation of GRK2 mediates exercise-induced alleviation of hypertension in spontaneously hypertensive rats
      Wenjuan Xing, Youyou Li, Haifeng Zhang, Chunjuan Mi, Zuoxu Hou, Michael J. Quon, Feng Gao
      American Journal of Physiology-Heart and Circulatory Physiology.2013; 305(8): H1111.     CrossRef
    • AMP-activated protein kinase activation mediates CCL3-induced cell migration and matrix metalloproteinase-2 expression in human chondrosarcoma
      Chin-Jung Hsu, Min-Huan Wu, Chin-Yuan Chen, Chun-Hao Tsai, Horng-Chaung Hsu, Chih-Hsin Tang
      Cell Communication and Signaling.2013;[Epub]     CrossRef

    • PubReader PubReader
    • Cite this Article
      Cite this Article
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      AMPK and Exercise: Glucose Uptake and Insulin Sensitivity
      Diabetes Metab J. 2013;37(1):1-21.   Published online February 15, 2013
      Close
    • XML DownloadXML Download
    Figure
    O'Neill HM. AMPK and Exercise: Glucose Uptake and Insulin Sensitivity. Diabetes Metab J. 2013;37(1):1-21.
    DOI: https://doi.org/10.4093/dmj.2013.37.1.1.

    Diabetes Metab J : Diabetes & Metabolism Journal
    Close layer